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ABSTRACT

Lactational Performance and Energy Partitioning of Dairy Cows
Supplemented with N-Acetyl-L-Methionine during Mid to Late lactation
by
Tyson George Grisenti, Master of Science
Utah State University, 2017

Major Professor: Dr. Jong-Su Eun
Department: Animal, Dairy, and Veterinary Sciences

The N-acetyl-L-methionine (NALM) molecule is a methionine (Met) derivative
produced via acetylation of the L-Met α-amino group with an N-acetyl group. This
molecule has been shown to be bioavailable and capable of fulfilling the dietary
requirement for Met in animals and humans. The current experiment was conducted to
test a hypothesis that lactating dairy cows fed with NALM would increase milk
production by increasing N and energy utilization efficiencies in a dose dependent
manner. Eight multiparous Holstein cows that were mid lactation (124 ± 13 days-in-milk)
with similar milk production were used in a 4 × 4 Latin square design for 84 d. A
developmental NALM product from CJ CheilJedang (Seoul, South Korea) was used as
the supplemental source of rumen-protected Met in the present study. Four dietary
treatments included 0 g (control), 15 g, 30 g, and 45 g/d/cow of NALM supplementation.
Supplementing NALM significantly increased dry matter intake (linear effect; P < 0.01),
while milk yield tended to increase quadratically (P = 0.07). A linear decrease in milk fat
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concentration was seen due to supplementation of NALM in relation to the control ration
(P = 0.02). However, milk fat yield was similar across treatments. A trend toward an
increase in milk protein yield was observed between the control ration and the ration
supplemented with 45 g of NALM (1.18 vs. 1.21 kg/d; P = 0.10). There were no
differences in energy-corrected or 3.5% fat-corrected milk yields in response to
treatments. It is likely that the supplementation of NALM to mid to late lactating dairy
cows may have shifted nutrient and energy utilization toward tissue gain and lactation,
which resulted in a decrease in feed efficiency for lactation (P = 0.02). Overall results
from the present study suggest that supplementing NALM to mid to late lactating cows
can increase milk yield in a dose dependent manner with a shift of net energy partitioning
toward milk production and body weight gain. In addition, supplementing NALM
increased milk nitrogen (N) output without affecting urinary N excretion.
(111 pages)
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PUBLIC ABSTRACT

Lactational Performance and Energy Partitioning of Dairy Cows
Supplemented with N-Acetyl-L-Methionine during Mid to Late lactation
Tyson George Grisenti

The N-acetyl-L-methionine (NALM) molecule is a methionine (Met) derivative
produced via acetylation of the L-Met α-amino group with an N-acetyl group. This
molecule has been shown to be bioavailable and capable of fulfilling the dietary
requirement for Met in animals and humans. The current experiment was conducted to
test a hypothesis that lactating dairy cows fed with NALM would increase milk
production by increasing N and energy utilization efficiencies in a dose dependent
manner. Eight multiparous Holstein cows that were mid lactation (124 ± 13 days-in-milk)
with similar milk production were used in a 4 × 4 Latin square design for 84 d. A
developmental NALM product from CJ CheilJedang (Seoul, South Korea) was used as
the supplemental source of rumen-protected Met in the present study. Four dietary
treatments included 0 g (control), 15 g, 30 g, and 45 g/d/cow of NALM supplementation.
Supplementing NALM significantly increased dry matter intake (linear effect; P < 0.01),
while milk yield tended to increase quadratically (P = 0.07). A linear decrease in milk fat
concentration was seen due to supplementation of NALM in relation to the control ration
(P = 0.02). However, milk fat yield was similar across treatments. A trend toward an
increase in milk protein yield was observed between the control ration and the ration
supplemented with 45 g of NALM (1.18 vs. 1.21 kg/d; P = 0.10). There were no
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differences in energy-corrected or 3.5% fat-corrected milk yields in response to
treatments. It is likely that the supplementation of NALM to mid to late lactating dairy
cows may have shifted nutrient and energy utilization toward tissue gain and lactation,
which resulted in a decrease in feed efficiency for lactation (P = 0.02). Overall results
from the present study suggest that supplementing NALM to mid to late lactating cows
can increase milk yield in a dose dependent manner with a shift of net energy partitioning
toward milk production and body weight gain. In addition, supplementing NALM
increased milk nitrogen (N) output without affecting urinary N excretion.
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INTRODUCTION

Multiple strategies have been employed in the dairy industry to decrease the cost of
production while maintaining or increasing milk and milk component production. One
method of improving profitability that has received considerable attention is to balance
the amino acid (AA) profile of the diet. Depending on the dietary composition, both
methionine (Met) and lysine (Lys) have been shown to be most limiting for milk
production (NRC, 2001), and Met has been identified as the most limiting AA for milk
protein synthesis (Schwab et al., 1976). Therefore, balancing for Met can potentially have
a significant impact on dairy production. Various commercial Met products, collectively
classified as rumen-protected Met (RPMet) products, have been developed using
different technologies to deliver bioavailable Met to the small intestine by protecting it
from degradation in the rumen. Physical protection of a Met molecule with coating
materials allows RPMet products to be effectively resistant to ruminal degradation.
Methionine analogues, a different type of RPMet product, are also widely used in the
dairy industry, and they utilize a hydroxyl group to protect them from ruminal
degradation (Schwab and Ordway, 2003). Despite extensive advancements with these
technologies, multiple studies have yielded mixed results on milk and milk component
production due to a variety of reasons, such as the method of rumen protection utilized,
dietary factors such as crude protein (CP) and metabolizable protein (MP) concentrations
(Lee et al., 2011), animal factors such as breed or stage of lactation (Patton, 2010), and
even organoleptic factors (Benefield et al., 2009). The use of Met for other physiological
functions by various tissues is also a plausible explanation for the inconsistent milk and
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milk component production responses to RPMet supplementation that has commonly
been overlooked.
Similar to milk production, Met is limiting for growth and body weight (BW) gain
(NRC, 2001), and thus the partitioning of Met and its influence on nutrient and energy
utilization for milk production and BW gain merits attention. It is commonly understood
that a shift occurs in the nutrient and energy partitioning of lactating dairy cows around
mid-lactation from milk production to BW gain (NRC, 2001). The components that affect
the partition of energy and nutrients have long been of interest to the industry, but are not
well understood (Friggens et al., 2013). Studies focusing on the influence of RPMet
supplementation on nutrient and energy partitioning are severely lacking and warrants
further investigation.
N-acetyl-L-Met (NALM) is a Met derivative, meaning it is a free Met molecule with a
chemical blocking group (an acetyl group) added to the α-amino group. The acetyl group
acts as a barrier that blocks the hydrolysis of the N-terminal of Met which protects it from
ruminal degradation (Wallace, 1992). A preliminary study done by our group (Fagundes
et al., 2016) reported that cows supplemented with NALM increased milk fat
concentration and yield, but not milk protein during early lactation. However, the effects
of NALM supplementation and the optimum rate of supplementation in mid to late
lactating cows may be different from the initial study due to the distinctive physiological
changes for cows in mid to late lactation compared to those in early lactation. Therefore,
the present study was performed to explore the effects of NALM supplementation on
production parameters and energy partitioning by mid to late lactating dairy cows. We
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hypothesized that an increase in metabolizable Met through NALM supplementation
would increase body tissue anabolism in a dose dependent manner rather than increasing
milk protein synthesis in mid to late lactation Holstein cows.
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REVIEW OF LITERATURE

With the advent of the multiple component pricing system in the U.S. dairy industry,
dairymen have sought out new and innovative ways to increase the production of both
milk protein and milk fat. Methionine has long been recognized as the first limiting AA
in milk protein synthesis (Schwab et al., 1976) and one of two limiting AA in milk
production (NRC, 2001). Met has also been shown to increase milk fat yield in mid
lactation (Overton et al., 1996; Schmidt et al., 1999). For this reason, feeding RPMet, or a
similar Met product, has gained popularity with dairyman. This literature review will
examine the many different methods that are available for providing Met to ruminants, as
well as their effects on feed intake, milk production, BW gain, and N utilization. Special
emphasis will be placed on acetylated AA, specifically NALM and the metabolic journey
it takes through the rumen, the small intestine, and the liver.

Methionine

Methionine and Ruminant Nutrition
The overall knowledge pertaining to applied ruminant nutrition in the dairy industry
has evolved immensely over the past few decades. It is now well known that ruminants
do not have a requirement for CP, per se, but rather a requirement for each of the ten
essential AA (EAA). Thus, when a ration is balanced for CP alone, protein may
potentially be underfed, limiting production, or protein may be overfed, decreasing
efficiency and increasing the output of nitrogenous manure waste. Balancing rations
according to the AA requirements of dairy cows, in theory, should overcome the
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uncertainty of over or underfeeding protein in traditionally balanced rations. Of all the
AA required by the cow, the most is known about Met.
Methionine is one of 4 AA that contain sulfur and only one of 2 sulfur-containing AA
that are proteinogenic (Brosnan, 2006). In ruminants, Met is an EAA, meaning Met
cannot be synthesized by the ruminant body in quantities sufficient to meet demands for
Met, so Met itself or a precursor for the synthesis of Met must be supplemented in the
diet. In mammals, including ruminants, Met is mainly used for the synthesis of new
proteins and the synthesis of S-adenosyl-methionine (SAM) (Preynat et al., 2009).
Synthesis of new proteins includes the synthesis of milk protein and, as mentioned
previously, Met is the first limiting AA in milk protein production. This means that milk
protein production is normally limited by Met, because it is in the shortest supply in view
of the AA requirements for milk protein production. SAM is a primary methyl donor for
multiple important biomolecules in all living organisms and is second only to ATP in its
use by cells as an enzyme substrate (Atta et al., 2004). Some metabolic health events,
such as fatty liver disease, can be combated with proper levels of SAM through sufficient
supplementation of dietary Met (Anstee and Day, 2012). In addition to aiding in the
metabolic health of the cow, Met aids in the methylation of DNA and is a precursor of
taurine and glutathione, both very important antioxidants (Osorio et al., 2014). Also, in
typical North American diets Met limits milk production in high-producing dairy cows,
especially when soybean meal is used as a protein source (Chen et al., 2011). It is very
apparent that Met is essential in milk and milk component production and is also very
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beneficial for the metabolic health of the ruminant, but not all forms of Met are equally
available and beneficial.

Methionine Isomers
There are 2 isomers of Met: the D and the L isomer. It is important to note that both
forms of Met are not equally available to the ruminant. In fact, the D isomer of any AA
has to be converted into an L isomer before they can be utilized. The L isomer of Met can
be utilized directly for protein synthesis without having to be converted to any other form
first; however, it is not known how much of the available D isomer of Met can be
converted to the L isomer to be utilized in ruminants. According to Lapierre et al. (2012),
the bioavailability of the D isomer of Met depends on the rate of transformation into the
L isomer. In monogastrics, this rate of transformation and subsequently the
bioavailability of D isomers is well studied (Baker and Boebel, 1980; Arentson and
Zimmerman, 1985), but there is a lack of data and information pertaining to this topic in
ruminant nutrition (Lapierre et al., 2012). Since RPMet products contain a racemic
mixture of both isomers, it stands to reason that it would be beneficial to investigate the
efficiency of the transformation of the D isomer in ruminants.
One of the only, and certainly the most current study on the bioavailability of D-Met
to dairy cows, was performed by Lapierre et al. (2012) using 4 multiparous cows in 3
different trials. In the first trial, all four of the cows received different treatments of DLMet in addition to an AA mixture. Trial 2 involved injections of L-Met and D-Met at
different time points. Finally, in trial 3 cows received injections of L-Met or DL-Met,
again at different time points and in addition to injections of an AA mixture. The results
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of these trials indicated that the removal rate for D-Met is slower than that of L-Met, as
little as one-sixth as fast in some instances. Also observed was the fact that most of the
D-Met is eventually transformed into the L-isomer at some unknown location in the body
(Lapierre et al., 2012). This is significant, because D-isomers cannot be extracted by the
mammary gland for milk or milk component production. So, D-Met can eventually be
utilized by the body after the slow uptake and slow conversion to L-methionine. This
then begs the question; what is the best way to deliver a steady supply of postruminal
bioavailable Met to the cow?

RPMet

Product Overview of RPMet
Many approaches have been taken in order to deliver the most amount of bioavailable
Met to the dairy cow. Many companies have employed various methods to efficiently
accomplish this goal. These methods typically include either physically coating Met with
different compounds or using compounds that can eventually be converted into Met.
Most rumen-protected AA products on the market today fall into one of three categories:
physically protected Met, Met analogues, or Met derivatives. Methionine analogues
technically are not classified as true rumen protected AA products, but they do offer
some level of rumen protection, so for the sake of this literature review I will classify
them as Met analogues. Each of these three types of products will be discussed in this
review.

8
By far the most popular method of delivering postruminal Met has been to physically
protect the AA from ruminal degradation. Lipids were initially used to protect Met from
ruminal degradation by coating the Met with tristearin, a triglyceride. The efficacy of Met
supplements is directly related to their ability to bypass the rumen and then be
bioavailable in the small intestine. This is where lipid coated Met products face their
biggest challenge. It is very difficult to find an effective lipid combination that allows for
both a high rumen escape rate and intestinal release rate of Met when using lipids as the
primary coating compound (Schwab and Ordway, 2003). Met-Plus (Nisso America, Inc.,
New York, NY), is one example of a lipid coated RPMet product that is available on the
market today, and it contains about 65% Met. Met-Plus appears to be the least studied
physically protected Met product because of the inefficiencies related to current lipid
coating technology.
The coating of the surface of Met molecules with carbohydrates came along after the
advancement of lipid coating technology, along with the hopes of improving the delivery
of bioavailable Met to the small intestine. Ethyl cellulose is used to coat a core of DLMet. According to Schwab and Ordway (2003), enzymatic digestion of ethyl cellulose is
minimal and, therefore, it is well protected from ruminal degradation. The problem that
arises with using ethyl cellulose is degradation of the product must come from physical
action and abrasion. This can reduce the amount of bioavailable Met delivered to the
small intestine. Mepron M85 (Evonik Industries, Hanau, Germany) is a popular example
of a carbohydrate coated methionine product. Mepron M85, as the name suggests,
contains a minimum of 85% DL-Met, which is 20% more than the previously mentioned
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Met-Plus. More important than the amount of Met in the product, is the amount of Met
that is bioavailable to the cow.
Smartamine M (Adisseo, Inc., Antony, France) provides the most bioavailable Met to
the cow when compared with other physically protected Met products, due in part to its
coating technology. Smartamine M, similar to Met-Plus, is a lipid coated product with the
difference being an additional coating of a pH-sensitive copolymer added to Smartamine
M (Schwab and Ordway, 2003). The addition of the copolymer allows for increased
protection in the rumen, which permits more Smartamine M to bypass the rumen. The
copolymer is degraded in low pH environments. After safe passage through the rumen,
Smartamine M will eventually reach the acidic environment of the abomasum where its
coating will dissolve allowing the DL-Met to travel on for absorption in the small
intestine. Smartamine M contains 75% DL-Met. This product is perhaps the most popular
physically protected Met product currently on the market; however, there are more
rumen-protected products available.
Another unique approach that has been taken to increase the amount of bioavailable
Met is to utilize Met analogues and derivatives. A commonly used Met analogue is 2hydroxy-4-(methylthio)-butanoic acid (HMB), also known as Met hydroxy analogue
(Phillips et al., 2003). HMB is technically not a true AA, but it can be converted into Met.
Methionine analogues are synthetically produced from the substitution of the α-amino
group of Met with a non-nitrogenous group, such as a hydroxyl group, as is the case of
HMB (Schwab and Ordway, 2003). The hydroxyl group is, in theory, supposed to
partially protect the Met analogue from ruminal degradation. This, however, does not
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appear to be an effective form of rumen protection with proportions of ingested HMB
that escapes the rumen being reported as low as 5% (Noftsger et al., 2005). This suggests
a ruminal mode of action, rather than an abomasal and small intestinal mode of action, or
in other words HMB is not technically a true form of RPMet (Noftsger et al., 2003).
Esterification of HMB to isopropanol (HMBi) does, however, appear to be an effective
form of rumen protection, according to St-Pierre and Sylvester (2005), with as much as
50% of HMBi escaping the rumen and being converted to Met (Ordway et al., 2009).
Alimet (Novus International, Inc. St. Louis, MO) and Rhodimet AT88 (Adisseo, Inc.,
Antony, France) are both products that contain HMB and are widely used in the poultry
and swine industries, with Alimet being approved for use in the dairy industry (Schwab
and Ordway, 2003). A more widely used product in the dairy industry is MetaSmart
(Adisseo, Inc., Antony, France), which is an HMBi product. MetaSmart consists of no
less than 57% HMBi, which is a 78% Met equivalent and of that percentage, 50% of it
would be absorbed and converted to metabolizable Met (Adisseo, Inc., Antony, France).
The use of Met analogues is a relatively new concept when compared with physically
protected Met, and the use of Met derivatives is an even newer concept.
Methionine derivatives are understudied and currently are not being utilized in the
dairy industry. A Met derivative is a free Met molecule that has had a chemical blocking
group added to the α-amino group or a Met molecule in which the acyl group has been
modified (Schwab and Ordway, 2003). Methionine derivatives differ from Met analogues
in the fact that it is adding to the α-amino group, rather than replacing the α-amino group.
The focus of this thesis is N-acety-L-Met (NALM), which is a Met derivative. Rumen
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protection, bioavailability, absorption, metabolism, and impacts on production of this
product will be discussed in detail later in this review. For now, I will focus on the
impacts of physically protected Met products and Met analogue products on all aspects of
production.

Factors Influencing RPMet Efficacy
Plenty of research has been conducted on the effects of Met supplementation on feed
intake, milk production, BW gain, and N utilization. The problem with the results of this
research, however, is that the overall results can be variable and inconsistent (Patton,
2010). One reason for the variability in these results can be attributed to the different
forms of Met being fed. Smartamine M, for example, has a core of DL-Met, and
MetaSmart is a Met analogue. Both products have different bioavailabilities, different
routes of absorption, and thus, different effects on production parameters. This needs to
be considered when comparing the effects of different Met supplement products on the
previously mentioned factors. Bioavailability and routes of absorption for these different
products will be discussed in further detail at another section in this review, so focus will
now be placed on other factors that can influence the efficacy of RPMet products.
One major factor influencing RPMet efficacy is the nutritional composition of the
experimental rations that are fed. When studying rumen-protected AA, total CP and MP
in the diet can have a major impact on the efficacy of RPMet products. Broderick et al.
(2008) observed that milk production increased when total CP in the diet was reduced
from 18.3% to 17.3% and then again to 16.1%, but when CP concentration was further
reduced to 14.8%, milk production was depressed, even with supplementation of RPMet.
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Broderick et al. (2008) also found that higher dietary CP concentrations led to an increase
in dry matter intake (DMI), milk fat and true protein (TP) concentrations, 3.5% fatcorrected milk yield , milk fat yield, TP yield, lactose yield, and solids-not-fat yield.
Similar to CP, decreasing MP also decreased milk production (Lee et al., 2011), whereas
it has been suggested that overfeeding MP can decrease milk production as well (Lee et
al., 2015a).
It has been suggested that some nutritional factors can have different effects on
different breeds of dairy cows. In an RPMet meta-analysis, Patton (2010) explained that
differences in production according to breed, can perhaps be explained by the nutritional
composition of the rations fed. For example, milk production was moderated in Holsteins
by neutral detergent fiber (NDF) and CP, whereas non-Holstein breeds were moderated
by energy balance. In the same meta-analysis on RPMet products, Patton (2010) noticed
that production responses were also influenced by the ingredient composition of the
rations fed. Alfalfa hay (AH)-based rations had greater milk production responses,
whereas rations that contained other forages besides AH, had reduced milk production
when Met was supplemented (Patton, 2010).
One major factor that could easily vary from trial to trial is days-in-milk (DIM), or the
location of the cow in her lactation cycle. Schwab et al. (1992) suggested that milk yield
did not readily respond to Met supplementation when cows were in mid to late lactation.
The findings in Patton’s meta-analysis (Patton, 2010) confirm Schwab’s thinking; Patton
(2010) found most cows in the studies had no response to Met supplementation, were
post-peak lactation and, they could have lacked the hormonal drive needed for increased
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milk production. Many other factors could come into play as well, such as parity and
breed of cow. Benefield et al. (2009) even suggested that the smell of certain products
could influence intake and thus production responses. The point proven here is there are
many factors that come into play when evaluating the efficacy of an RPMet product,
especially when comparing one product to another.

Effects on Feed Intake
Feed intake, also known as DMI, is arguably one of the more important animal
responses that should be considered on dairy studies. In general, DMI is directly
proportional to positive responses in many aspects of dairy trials, including the health and
production of the cow. For example, every extra kg of DMI above the requirements of
maintenance provides enough energy to potentially support 2 kg of milk production
(Amaral-Phillips et al., 1997). Multiple factors can affect DMI, including the nutritional
composition of the diet fed. For instance, keeping focused on AA and protein,
supplemental histidine in the diet has been shown to increase DMI (Lee et al., 2012;
Giallongo et al., 2016) and deficient MP supplies have been proven to decrease DMI (Lee
et al., 2011). In some cases, feeding supplemental Met, in any of the above mentioned
forms, can have an impact on DMI. In a meta-analysis study conducted by Zanton et al.
(2014) that investigated the effects of Mepron M85, Smartamine M, and HMB on
lactational performance, it was reported that DMI was affected by the source of
supplemental Met. In fact, it has been suggested that Met, if fed at high concentrations,
can have a negative effect on DMI and is the AA that has the potential to impact DMI the
most (Benevenga, 1974).
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Response in DMI to Met supplementation has been inconsistent and variable.
Smartamine M seems to be the most studied RPMet product on the market today and,
therefore, there are multiple recorded DMI responses to supplementation of Smartamine
M. Osorio et al. (2014) supplemented Smartamine to transition dairy cows, from 21 d
pre-partum to 30 d post-partum. An overall post-partum increase in DMI was noted, with
an even more pronounced increase in DMI seen from 7 d to 30 d post-partum.
Conversely, Socha et al. (2005) also in post-partum cows, found a decrease in DMI when
supplemented with Smartamine M. Studies have also shown that supplementation of
Smartamine M can have no effect on DMI, as is the case with Chen et al. (2011). When
compared with other types of Met products, Smartamine M seems to have a more
pronounced effect on DMI in some cases. Cermakova et al. (2012) demonstrated that
dairy cows supplemented with Smartamine M had significantly higher DMI than those
supplemented with MetaSmart. Responses in DMI with other products have also been
seen.
Mepron M85, another physically protected Met product, has been shown in multiple
studies to decrease DMI. Zanton et al. (2014) reported that Mepron M85 decreased DMI
when compared with their respective control cows. Similarly, Benefield et al. (2009)
observed a decrease in DMI after supplementation of Mepron M85. MetaSmart, a Met
analogue, has been shown to both increase and decrease DMI. Osorio et al. (2014)
demonstrated that MetaSmart fed to post-partum cows, increased DMI. An increase in
DMI upon supplementation of Met analogues is understandable, because it has been
reported that Met analogues have a stimulatory effect on certain rumen bacteria, which
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could increase passage rate, thus increasing DMI (Lee et al., 2015b). In contrast,
Cermakova et al. (2012) reported a decrease in DMI in MetaSmart supplemented cows
when compared to those fed a control diet. There are multiple other examples of both
increases and decreases in DMI being reported with supplementation of different Met
products. It seems the current data on DMI related to Met supplementation is very
variable and may not be reliable. More research needs to be conducted on the variables
that are related to Met supplementation and DMI under different physiological
conditions.

Effects on Milk and Milk Component Production
Beginning in 2000, the Federal Milk Marketing Administration implemented the
multiple component pricing system (AMS-USDA, 1999). This means there is a monetary
value on the pounds of fat, protein, and other solids in the milk that are produced rather
than just total volume of milk produced. To maximize producers’ milk check, dairy
farmers focus on fat and protein concentrations in the milk and total milk volume. Other
solids and solids-not-fat are hard to manipulate, unlike milk fat and milk protein, and also
do not yield nearly as good of an economic return as do milk fat and milk protein. For
that reason, other solids is usually not a main focus of dairy producers today. Therefore,
this literature review will only focus on the effects of Met supplementation on milk, milk
fat, and milk protein production and how different RPMet products affect production in
their own separate ways.
Total volume of milk produced per cow per day, or the herd average milk production,
is the glory number on any dairy. It is often used as a benchmark number, or a way to
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compare how well a dairy is performing. More practically, this number directly correlates
with how many pounds of milk fat and milk protein the dairyman will get paid for, and
for that reason it is of great importance to focus on increasing milk production. The best
and most recorded responses in milk production have come through the use of physically
protected Met products, especially Smartamine (Rulquin et al., 2006). After compiling
data from 18 different studies that used Smartamine, Patton (2010) reported that on
average across all 18 studies, an increase in milk production was observed. Mepron has
also shown multiple positive responses in milk production (Lara et al., 2006; Broderick et
al., 2008). Some studies have also shown no response in milk production with
supplementation of Smartamine (Rulquin et al., 2006) and Mepron (Leonardi et al. 2003).
In spite of the fact that some studies show no response, physically protected Met products
still prove to be effective in increasing milk production (Chen et al., 2011).
Some Met analogue products, such as MetaSmart, can also have a positive impact on
milk production, but not all Met analogue products show such positive results. In review,
there are two types of Met analogues, 2-hydroxy-4-(methylthio)-butanoic acid or the
isopropyl ester of HMB; both have different effects on milk production. Generally, HMB
does not affect milk production, but HMBi, because of its significant metabolizable Met
supply to dairy cows, has the potential to increase milk production (Rulquin et al., 2006).
Many studies have compared the two Met analogues and their effects on milk production.
St-Pierre and Sylvester (2005) compared two popular Met analogue products-Alimet
(HMB) and MetaSmart (HMBi). They found milk production in cows supplemented with
HMB was not affected by HMB, but those supplemented with HMBi produced an
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additional 2.9 kg of milk when compared with the control cows. Noftsger et al. (2003 and
2005) has suggested the reason HMB does not help increase milk production is because it
is not a major source of metabolizable Met, but rather it acts in the rumen and influences
the microbial populations of the rumen. Lee et al. (2015b) had similar findings by
supplementing HMB, as they observed a 1 kg numerical decrease in milk production for
every 0.05% of dry matter (DM) increase in HMB. In periparturient cows, Piepenbrink et
al. (2004) actually found a quadratic increase in milk production with HMB
supplementation with a decrease occurring at a supplementation rate of 45 g/d of HMB.
The rumen protected isopropyl ester of HMB (HMBi) has proven to have a somewhat
better response with increasing milk production. Confirming the findings of St-Pierre and
Sylvester (2005), Xia et al. (2012) reported an increase of up to 3.9 kg/d milk yield with
supplementation of HMBi both pre and postpartum. Methionine analogues have been
proven to be more effective in increasing milk fat, rather than total milk yield.
Unlike milk production, milk fat production shows a more positive response to HMB
and HMBi supplementation. The use of HMB has been studied for a longer period of
time than HMBi and, therefore, there are earlier studies that show the effect of HMB on
milk fat production. In fact, there are multiple early studies that show a positive response
in milk fat production from supplementation of HMB (Holter et al., 1972; Lundquist et
al., 1983; Huber et al., 1984). Interestingly enough though, the results of current studies
pertaining to milk fat production and HMB are mixed and not conclusive (Lee et al.,
2015b). In contrast, HMBi has recently received a lot of attention and has shown an
ability to increase milk fat production. Xia et al. (2012), when comparing milk fat
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production in cows supplemented with HMBi post-partum and pre/post-partum to control
cows, reported an increase in milk fat yield (1,120 and 1,160 vs. 980 g/d, respectively).
St-Pierre and Sylvester (2005) also noticed an increase of 166 g/d of milk fat yield with
HMBi supplementation. Traditional RPMet products, such as Smartamine and Mepron,
are not usually associated with increases in milk fat production, but rather with increases
in milk protein production.
True rumen-protected forms of Met, normally do not contribute to an increase in milk
fat because of their lack of a ruminal mode of action, unlike HMB and HMBi. Many
responses in both milk protein concentration and yield have been recorded for RPMet
products such as Smartamine and Mepron. Patton (2010) who summarized the findings of
35 studies (17 evaluating Mepron and 18 evaluating Smartamine) showed, on average,
supplementing these products increased both milk protein yield and concentration. Many
studies have also been conducted comparing true RPMet products to Met analogue
products and their effects on milk protein yield. Ordway et al. (2009) showed an increase
in milk protein concentration in cows fed MetaSmart as well as Smartamine compared to
those fed a control diet. Osorio et al. (2013) observed an increase in milk protein yield,
but they reported a larger increase in Smartamine supplemented cows when compared
with those supplemented with MetaSmart (1.24 vs 1.23 kg/d). The findings of Rulquin et
al. (2006) also confirm the results of Osorio et al. (2013) in that Smartamine
supplemented cows produced more grams per day of milk protein than MetaSmart
supplemented cows, and both groups produced more than the control group. The
important message here is when Met is made available post-ruminally, whether it be

19
through RPMet products or Met analogue products, milk protein is increased.
Methionine, if not utilized by the cow for milk and milk component production, can also
potentially play a pivotal role in BW gain.

Effects on BW Gain
Effects of supplemental Met on BW gain in dairy cattle seems to be sparse and
lacking. However, in other species information concerning this topic is abundant; for
example, in the poultry industry supplementation of dietary Met is a common practice
and is well researched. Lemme et al. (2002) found a positive response in BW gain, feed
conversion, carcass yield, and breast meat yield with supplementation of both DL-Met
and HMB, with better responses coming from DL-Met supplementation. Similarly,
Meirelles et al. (2002) concluded that DL-Met increased BW gain and feed conversion
more than HMB, although HMB also increased BW gain and feed conversion when
compared with a control diet. In both studies HMB was found to have an efficacy on
weight gain of about 65% when compared with DL-Met as a source of dietary Met
(Lemme et al., 2002; Meirelles et al., 2002). Growing pigs also respond positively in
weight gain and feed conversion to Met supplementation. Zimmermann et al. (2005)
reported that pigs supplemented with DL-Met or HMB had higher weight gains than
those consuming a control diet (501 and 488 g vs. 432 g). Very little information
concerning Met supplementation and BW gain in dairy cows is available, but there is
information on other ruminants.
Although there is data concerning weight gain in steers and lambs supplemented with
Met, this data has been inconsistent and quite disappointing. Some studies showed
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positive responses in BW gain and feed efficiency with supplementation of RPMet
(Deetz et al., 1985; Oke et al., 1986). Others, such as Strasia et al. (1986) reported no
response in BW gain. More recently, Hussein and Berger (2014) observed no response in
BW gain with as much as 50 g of RPMet supplementation to Holstein steers. A lack of
response to RPMet supplementation suggests that Met was not limiting in these
experimental diets. Data on the effects of supplementation of Met analogues and
derivatives are currently even more sparse and lacking than that of true RPMet
supplementation. Even though BW gain results have been somewhat disappointing, Met
has the potential to aid in BW gain in diets where Met is the most-limiting AA.
Similar to milk protein synthesis in dairy cattle, Met is the first-limiting AA in
growing cattle (Richardson and Hatfield, 1978). This is significant, because Met
functions as a precursor for protein synthesis and, therefore, a deficiency of Met will lead
to a decrease in the turnover of dietary protein into protein deposition in the body, thus
limiting potential BW gain (Loest et al., 2002). In competition with its use for protein
synthesis, Met can also be converted to SAM in the liver, which acts as a methyl group
donor for many transmethylation reactions (Finkelstein, 1990). SAM aids in the
formation of phospholipids (Obeid and Herrmann, 2009), which in turn aids in the
formation of the phospholipid bilayer of very low density lipoproteins (VLDL). Then,
VLDL carries triglycerides, which, especially in finishing cattle, aids in fat deposition
and intramuscular marbling, leading to an increase in BW gain (Dodson et al., 2010).
Methionine has the potential to positively affect BW gain, but more research needs to be
performed to clearly understand its mechanism.
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Effects on N Utilization
Unlike the effects of Met supplementation on BW gain, the effects of Met
supplementation on N utilization are well known and reported. As discussed earlier,
supplementation of RPMet can increase milk yield (Patton, 2010) and milk protein yield
(Ordway et al., 2009). Therefore, the use of RPMet may allow for the feeding of less CP
in diets without adversely affecting production (Broderick et al., 2008). Reducing dietary
CP concentration, while maintaining production, could potentially have a huge impact on
N utilization and excretion, because when dairy cows are fed to meet MP requirements,
they consume excessive N, resulting in 75% of the dietary N consumed being lost to the
environment in urine and feces (Arriola Apelo et al., 2014). This potential decrease in N
utilization is important today because of the need to continue to feed the increasing world
population while focusing on the ever-present environmental concerns (OECD/FAO,
2015).
Many studies show a positive response in production and a decrease in N excretion in
relation to a decrease in dietary CP accompanied by Met supplementation. Broderick et
al. (2008) conducted a trial in which dietary CP was reduced from 18.6% to 14.8% with
an increase in RPMet supplementation from 0 to 15 g/d in four different diets. As
expected, significant increases in milk production and N efficiency were observed: 39.7
to 41.6 kg/d milk yield and 26.2 to 31.7% N utilization. Supplementation of HMB has
also proven to increase both milk production and N efficiency. Wang et al. (2010)
observed that upon HMB supplementation in a MP deficient diet, milk production was
increased from 26.5 to 28.5 kg/d coupled with N efficiency improvement from 26 to
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28.3%. In both studies, excretion of N was reduced in milk, urine, and manure. The
ability to reduce dietary CP while maintaining or increasing production is of great value
when focusing on the potential environmental impact of dairying.

Economic Analysis
The worth of Met supplementation to a dairyman hinges on a positive return on
investment. Dairymen routinely measure their return on investments in terms of the cost
invested to increase milk and milk component production compared with how much milk
and milk component production actually increases. Currently, as this review is being
written, the market price of class III milk is $16.74 per hundredweight (CWT)
(www.cmegroup.com; May 2017), $2.05 per lb. of milk fat, and $2.30 per lb. of milk
protein (www.milkpay.com; May 2017). Smartamine, a popular RPMet product, is
currently priced at $6.72 per lb., and the recommended feeding rate is 12 g/cow/d,
depending on dietary deficiency of Met. Metasmart, a popular HMBi Met analogue
product, is currently priced at $2.73 per lb. and the average feeding rate is 40 g/cow/d. At
the average feeding rate the cost of feeding Smartamine would be $0.18/head/d, whereas
the cost of feeding Metasmart would be $0.24/head/d. At the current cost of milk, a dairy
farmer would need to produce 1.08 lbs. of extra milk to cover the cost of investment in
Smartamine and an extra 1.43 lbs. of milk to cover the cost of investment in Metasmart.
Both of those numbers are attainable. It is important to note, and has been discussed
previously in this review, that Smartamine and Metasmart can have different impacts on
milk component production. Dependent on the targeted milk component, either
Smartamine or Metasmart may have the biggest financial impact for the dairy producer.
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Acetylated AA

Although the aforementioned methods of supplying useable Met to dairy cows have
been successful, the ever-evolving dairy industry is always looking for new and improved
methods of increasing production and herd health, while decreasing the environmental
impact of dairying. As another way of delivering bioavailable AA to the dairy cow,
acetylation of AA has garnered attention. Acetylation of AA occurs when the NH2terminals of AA are acetylated with an acetyl group (Gade and Brown, 1981). The
beginning products of this reaction are L-AA and acetic anhydride (EFSA, 2003). The
purpose of acetylating AA is to protect the N-terminal amino group from hydrolysis by
rumen microbes (Wallace, 1992). The acetylation process is not new; however, the use of
acetylated AA in ruminant nutrition is new and as a result of this, research pertaining to
this topic appears to be sparse.

Bioavailability
As a result of the chemical makeup of acetylated AA (L-AA and an acetyl group), the
bioavailability of the AA in question depends on the separation of the AA and the
attached acetyl group. The acetyl group acts as a barrier that blocks the hydrolysis of the
NH2-terminal of the amino acid which protects it from ruminal degradation (Wallace,
1992). The protection provided by the acetyl group also prevents absorption of the
attached AA in the small intestine. Thus, acetylated AA themselves are not bioavailable,
per se, until the acetyl group and attached AA are separated. The hydrolytic reaction that
separates these 2 compounds is catalyzed by an enzyme called acylase 1 or aminoacylase

24
1 (Baxter et al., 2001). This enzyme is found in multiple mammalian tissues, including
the small intestine, which is the most important site in the study of the bioavailability of
acetylated AA (Giardina et al., 1997).
The hydrolytic reaction separating the acetyl group and the AA is not possible without
the aminoacylase 1 enzyme, thus the bioavailability of acetylated AA is dependent on the
presence of the aminoacylase 1 enzyme, and the bioavailability can be predicted based on
the ability of aminoacylase 1 to catalyze this hydrolytic reaction (Baxter et al., 2001).
Furthermore, Gade and Brown (1981) found that the aminoacylase enzyme is the major
and the only enzyme that catalyzes the hydrolysis of acetylated AA, especially acetylated
Met. Therefore, if the aminoacylase enzyme is the only enzyme capable of hydrolyzing
acetylated AA, then the theory of Baxter et al. (2001) that states the bioavailability of
acetylated AA is directly related to the amount of enzyme present and the ability of this
enzyme to catalyze hydrolytic reactions, holds true. Baxter et al. (2001) reinforced their
hypothesis by studying the hydrolytic effects of aminoacylase on N-acetyl-L-glutamine
(NAQ) and NALM. They concluded that the hydrolyzation of both NAQ and NALM was
linearly dependent on the concentration of aminoacylase and time (Baxter et al., 2001).
Another way to investigate the efficacy of aminoacylase is to measure the Km and Vmax of
the enzyme.
An easy and simple way to define Km and Vmax, in the context of the aminoacylase
enzyme, is that Km is a measure of how easily and quickly aminoacylase binds to
acetylated AA, and Vmax defines how fast aminoacylase can catalyze the hydrolytic
reaction to yield the L-AA and an acetyl group (Dixon et al., 1979). Galaev and Svedas

25
(1982) found the Km constant of the hydrolysis of acetyl-L-Met by aminoacylase to be
0.14 ± 0.03 M while Baxter et al. (2001) found a Km constant of 0.00136 ± 0.00015 M.
The low Km constant values presented in the two studies above suggest that aminoacylase
binds to acetylated AA quickly and easily, or in other words aminoacylase has a high
affinity for acetyl-L-Met and only a small amount of substrate is needed to saturate the
enzyme. The Vmax of this same reaction is not quite as fast, when compared with the
hydrolysis of other acetylated AA. The Vmax, as found by Baxter et al. (2001) is
7.48 ± 0.28 nM Met/min/µg acylase 1. When comparing the Km and the Vmax of the
hydrolytic reaction of acetyl-L-Met, one can conclude there is a high affinity for the
substrate, but once it is saturated the reactions proceeds to completion at a moderate pace.
One can also conclude in the presence of aminoacylase and upon completion of the
hydrolytic process, much of the free AA released by this process will be bioavailable to
the dairy cow. There are, however, other factors which may influence the efficacy of this
hydrolytic process.
One major factor that influences the efficacy of hydrolyzing acetylated AA is the type
of AA isomer being utilized. Birnbaum et al. (1952) concluded acetylated D-isomers of
AA were hydrolyzed much more slowly than their corresponding L-isomers. Similarly,
while studying the bioavailability of different acetylated AA, Boggs (1978) found
comparable results to Birnbaum et al (1952). Boggs (1978) fed N-acetyl-D-Met and
NALM in diets deficient in Met to rats under similar conditions. Growth of rats fed
NALM was 62.7 ± 9.5 g/d, while the growth of rats fed N-acetyl-D-Met was 23.9 ± 0.6
g/d, which clearly supports the assumption that acetylated D-isomers of Met are not as
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bioavailable as the L-isomer. The pH at the location of enzymatic activity can also
greatly influence the hydrolytic efficacy of the aminoacylase enzyme. Gade and Brown
(1981) found the optimum pH for which aminoacylase can most effectively hydrolyze
acetylated AA was approximately 8.5. In the pH range of 6.0 to 10.3, enzymatic activity
was still 90% effective, but when the pH dropped down to 3.8, no enzymatic activity
could be detected. Similarly, Galaev and Svedas (1982) concluded the optimum pH range
of aminoacylase activity was somewhere around a pH of 7.0 – 8.0. The pH in the small
intestine of ruminants falls in the range of 7.0 – 8.0, which creates the perfect pH
environment for the hydrolyzation of acetylated AA. The concentration of aminoacylase
in the small intestine is very high (Boggs, 1978). Thus, because of the optimal pH
conditions in the small intestine and the high concentration of aminoacylase in the small
intestine, the potential bioavailability of the free AA released from the hydrolytic process
will be high.

Bioavailability of Other Met Supplements

Unlike acetylated Met, the bioavailability of RPMet and Met analogues is more wellknown and studied. Many different methods of delivering useable Met to the dairy cow
have been described above and although they all have the same objective in mind of
protecting the Met in the rumen, the bioavailability of these different methods and
products differs. Understanding and studying the bioavailability of these different
products is important in determining their efficacy in the dairy industry, because although
all of these products provide useable Met to some degree to the dairy cow, dairy
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producers should choose a product based on its ability to provide the most bioavailable
Met to the cow. The bioavailability of RPMet products is ultimately determined by the
Met concentration of the product, the ruminal stability of the product, and the intestinal
release of the product (Berthiaume et al., 2000). The bioavailability of different rumenprotected products and different Met analogue products will be discussed in detail.

Bioavailability of RPMet
As stated above, it stands to reason the Met concentration of RPMet products directly
influences the degree of bioavailable Met delivered to the small intestine. As discussed in
the RPMet Product Overview section of this literature review, different RPMet products
have differing concentrations of DL-Met. As far as true RPMet products are concerned,
potentially the most popular commercial product, Smartamine (Adisseo, Inc., Antony,
France) contains 75% DL-Met, while another popular product, Mepron (Degussa
Corporation, Germany) contains 85% DL-Met, and Met-Plus (Nisso America, Inc., New
York, NY) has 65% DL-Met. In review, Met analogues do not contain DL-Met, but
rather they contain the compound 2-hydroxy-4-(methylthio)-butanoic acid, which
eventually can be converted to Met. Metasmart (Adisseo, Inc., Antony, France), the
isopropyl ester form of HMB, is potentially the most popular Met analogue available on
the market. MetaSmart consists of no less than 57% HMBi, which is a 78% Met
equivalent, and of that 50% is reported to be absorbed and converted to metabolizable
Met. Therefore, the actual concentration of Met in each of the products varies, with
Mepron containing the most Met (85%). Although the concentration of Met in each of the
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products is important, it does not independently dictate the amount of bioavailable Met in
the product itself, ruminal degradation also influences this.
Ruminal degradation rate, or ruminal outflow rate, of any RPMet product is
influenced by the particle size and density of the product (Koenig and Rode, 2001).
Adisseo Inc., reports a particle size of 1.4 to 2.5 mm and a density of 0.7 g/cm3 for
Smartamine and a particle size of approximately 0.3 mm and a density of 0.75 g/cm3 to
0.80 g/cm3 for MetaSmart, while Degussa Corporation reports a pellet particle size of
1.8 × 3 mm and a density of 0.71 g/cm3 for Mepron. To compare how particle size affects
ruminal outflow rate, Smartamine has a mean rumen retention time of 31.9 h in lactating
dairy cows (Mambrini and Peyraud, 1997). Also influencing ruminal outflow rate is the
form of protection used to help Met bypass the rumen. Smartamine uses a pH-sensitive
polymer coating (Adisseo, Inc., Antony, France), and Mepron uses a coating of ethyl
cellulose (Degussa Corporation, Germany) to protect a core of DL-Met, while MetaSmart
utilizes the analogue HMBi (Adisseo, Inc., Antony, France), which will be converted to
Met after being absorbed. Differing particle sizes, densities, and forms of rumenprotection result in differing bioavailabilities. Schwab and Ordway (2003) reported
average ruminal outflow rates of 90% for Smartamine and 80% for Mepron. In other
words, 90% and 80% of ingested Smartamine and Mepron, respectively will pass
undegraded through the rumen to the acidic abomasum where the encapsulated Met will
be released. MetaSmart has a rumen bypass rate of 50%, although technically MetaSmart
does not bypass the rumen in the traditional manner (Adisseo, Inc., Antony, France).
MetaSmart is absorbed across the rumen wall where it then becomes bioavailable. After
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assessing the Met content and the rumen bypass rate of an RPMet product, the abomasal
release and intestinal absorption of the product needs to be determined in order to
quantify the potential efficacy of the product in question.
Once RPMet products, with the exception of Met analogues, bypass the rumen and
enter the abomasum, the encapsulated Met is released in the acidic abomasal environment
where it then passes onto the small intestine. Similar to Met concentration and ruminal
bypass rate, the rate of release of Met from the abomasum and the subsequent absorption
rate in the small intestine, differ among all products. One way to measure intestinal
absorption is to measure the intestinal disappearance of Met expressed as a percentage of
total Met entering the small intestine from the abomasum. Koenig and Rode (2001) stated
that the intestinal disappearance rate of Mepron averaged 31.9%, while Sudekum et al.
(2004) similarly found an average Mepron intestinal disappearance rate of 28%. Schwab
and Ordway (2003) reported an average intestinal disappearance rate of 90% for
Smartamine. This large difference in intestinal disappearance between Mepron and
Smartamine can most likely be attributed to the difference in the form of rumen
protection employed in the products, and the efficacy of the eventual release of Met. The
polymer coating of Smartamine is degraded in low pH environments, while the coating of
Mepron is degraded through abrasion and physical breakdown, which may not be as
reliable as the pH-sensitive Smartamine coating. After assessing the Met concentration,
the ruminal bypass rate, and the intestinal disappearance rate, the bioavailability of the
RPM product can be calculated.
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Berthiaume et al. (2000) stated that RPMet bioavailability is based on the products’
AA concentration, their ruminal stability, and intestinal digestibility. Similarly, Koenig
and Rode (2001) defined RPMet bioavailability as a combination of effective ruminal
degradability and intestinal disappearance with the actual calculation being (100 –
effective ruminal degradability) × intestinal digestibility. Based on these calculations,
Koenig and Rode (2001) found the bioavailability of Mepron to be a low 23.6%. In
comparison, only 25 to 35% of feed protein in normal dairy rations reaches the small
intestine. By this comparison, Mepron does not seem to be an effective source of
bioavailable Met. Contrary to the findings of Koenig and Rode (2001), the Degussa
Corporation reports a bioavailability of 80 to 85% for Mepron. Abdi-Benemar (2016)
reported a bioavailability of 61% for Mepron, which is closer to the bioavailability
reported by Degussa Corporation. These differences in the bioavailability of Mepron may
arise from the ethyl cellulose matrix coating of this product. The coating of this product is
designed to be thinner at both ends of the pellet so that both ends can be opened, and the
DL-Met core can be solubilized and flushed out of the pellet (Berthiaume et al., 2000).
The problem that potentially may arise with this mode of action is that Mepron relies on
abrasion and physical forces for the degradation of the ethyl cellulose coating, rather than
relying on enzymatic or pH activity, which may lead to a decrease of available
methionine (Schwab and Ordway, 2003). Unlike Mepron, Smartamine relies on a pHsensitive polymer coating to protect the DL-Met core, which makes estimating
bioavailability more constant and easier. According to Robert and Williams (1997), the
bioavailability of Smartamine falls somewhere between 75 to 97%. Similarly, Graulet et
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al. (2005) determined the bioavailability of Smartamine to be 74%. Providing more
evidence to the consistency of the bioavailability of Smartamine, Schwab (1995) found
the bioavailability to be 80%. Although Met analogues are different in both composition
and their mode of action from traditional RPMet products, the bioavailability of Met
analogues can still be assessed and compared to the bioavailability of RPMet products.
Graulet et al. (2005) compared the Met bioavailability of HMBi with that of Smartamine
and found the Met bioavailability of HMBi and Smartamine to be 48 and 71%,
respectively. This is in accordance with estimations from Robert et al. (2001, 2002) of a
bioavailability of 40 to 58% for HMBi. According to the studies cited, Smartamine
provides the most bioavailable Met to the dairy cow, which creates a standard for the
future bioavailability studies of Met derivatives.

Absorption of NALM in the Small Intestine

The use of acetylated AA in ruminant nutrition is a fairly new concept, and
consequently information concerning its bioavailability is sparse. In review, acetylation
of AA occurs when the NH2-terminal of an AA is protected with an acetyl group (Gade
and Brown, 1981). The purpose of acetylating AA is to protect the N-terminal amino
group from hydrolysis by rumen microbes (Wallace, 1992). Once NALM bypasses the
rumen and arrives at the small intestine, the aminoacylase enzyme hydrolytically
separates the acetyl group from the L-Met molecule, thus making both the acetate and the
L-Met molecule available for absorption in the small intestine. Providing both an acetyl
group and an L-Met molecule is a very unique aspect of NALM that distinguishes it from

32
other RPMet or Met analogue products. Without the separation of these 2 molecules,
however, L-Met would not be available for absorption in the small intestine.

Intestinal Absorption of AA
Once AA reach the small intestine, they can be incorporated into protein (constitutive
or secretions), converted into other AA for biosynthetic processes, oxidized to CO2, or
transported through enterocytes into the mesenteric portal vein (Stoll and Burrin, 2006).
The small intestine is divided into three distinct regions consisting of duodenum,
jejunum, and ileum. Absorption rates differ in each of the different sections of the small
intestine and the site where the majority of AA absorption occurs differs according to
species. In ruminants, it is believed that the majority of AA absorption occurs in the
ileum (Webb and Matthews, 1994). Williams (1969) also proposed that the site of AA
absorption can change according to the AA being absorbed. For example, Williams
(1969), in agreement with Webb and Matthews (1994), found that the majority of AA
absorption occurred in the ileum of sheep with the exception of Met which was absorbed
in equal amounts in the jejunum and ileum. Similar to the influence of AA on the site of
absorption, they can also have an impact on the absorption rate, or in other words,
different AA are absorbed at differing rates. Armstrong et al. (1977) and Christiansen and
Webb (1990) observed that Met was absorbed at the greatest relative quantity when
compared to all other AA. Likewise, the mode of transportation and the mechanism used
to transport AA through the enterocytes can differ according to the individual AA.
Amino acids can be transported from the intestinal lumen to the enterocytes through
either simple diffusion, facilitated diffusion, or active transport (Wilson and Webb,

33
1990). Facilitated diffusion mechanisms are also known as sodium-independent systems,
and active transport is referred to as sodium-dependent transport. Sodium-dependent
systems require energy to pump AA into the cell. This process is regulated by Na+/K+
ATPase, which pumps Na and AA into the cell and K out of the cell (Webb and
Matthews, 1994). Sodium-independent systems do not require energy to pump AA into
the cell. Amino acid concentration in the small intestine dictates which transportation
method is utilized. Only when concentrations of AA are low does transportation through
facilitated diffusion, and active transport exceed absorption through simple diffusion
(Wilson and Webb, 1990). Amino acid transport systems can also be classified according
to substrate preference (Wu, 2013). Many transport systems have an affinity for more
than one substrate.
It is important to recognize the AA profile that reaches the small intestine will not be
the same AA profile that will be absorbed through the enterocytes and enter the portal
circulation. As stated earlier, AA can be oxidized for energy or utilized for other
purposes, such as cellular protein synthesis or mucin production, in the small intestine.
As these AA are irreversibly utilized, they are then nutritionally unavailable to the cow
(Stoll and Burrin, 2006). Depending on the AA in question, small intestinal metabolism
could drastically change the amount available for absorption. As much as 20-90% of
dietary AA can potentially be catabolized in and by the small intestine, depending on the
AA (Wu, 2013). Measurements of AA disappearance in the ruminant small intestine is
lacking, but there are studies concerning AA disappearance in the monogastric small
intestine. In similar swine studies, Wu et al. (2010) and Stoll and Burrin (2006) found
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some AA, such as glutamate and aspartate, are almost completely catabolized by the
small intestine and nearly 30% of Met is metabolized. In contrast, Seal and Parker (2000)
suggested only 20% of the ruminants’ small intestinal AA requirement comes from
lumen-derived dietary AA, with the rest being derived from the arterial supply of AA.
Stoll and Burrin (2006) suggested the reason oxidation of AA in the small intestine can
potentially be high compared to any other substrate is because it is the body’s way of
meeting the high metabolic demands of the small intestine while preserving and ensuring
the delivery of glucose, the bodies’ most important energy substrate, to the peripheral
tissues. Once AA are transported into the enterocytes, catabolization appears to be
negligible. Chen et al. (2009) reported that catabolism of Met in piglet enterocytes was
negligible. Amino acids travel through the enterocytes where they pass through the
basolateral membrane and enter mesenteric circulation on their way to the liver.

Liver Metabolism

The liver is a very large organ that is essential for nutrient metabolism and nutrient
distribution in the body. The liver has a variety of functions including detoxification of
certain substrates, decomposition of red blood cells, protein synthesis, hormone
production and removal, triglyceride production, control of feed intake, and bile
production, just to name a few. However, one of the main functions of the liver is to filter
the hepatic portal vein blood before allowing it to pass to the rest of the body. In
ruminants, blood accounts for 25% of the livers mass, and the liver receives 25% of the
cardiac output (Lobley et al., 2000). Blood supply to the liver comes from both the
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hepatic portal vein and the hepatic artery. The hepatic artery only contributes 8-12% of
total hepatic blood flow in cattle and sheep, with the rest of blood flow coming from the
hepatic portal vein (Lobley et al., 2000). Blood flow to the liver through the hepatic
portal vein is not controlled by the liver itself and is actually inversely related to arterial
supply of blood to the liver (Lautt, 1996). Lobley et al. (2000) suggested that adenosine
released in the liver and the subsequent removal of adenosine through hepatic and arterial
flows may be responsible for regulating hepatic blood flow. In the hepatic portal vein,
AA are carried to the liver in the plasma and not in the red blood cells (Houlier et al.,
1991).

Liver Removal of AA
Similar to the small intestine, when AA reaches the liver they can either pass directly
through the liver to be utilized either in peripheral tissues, or in the liver for synthesis of
proteins, urea, or glucose (anabolism), or they may also be oxidized (catabolism)
(Bequette et al., 2003). The liver has the difficult function of ensuring a sufficient supply
of AA to peripheral tissues while maintaining non-toxic levels of AA in the bloodstream.
Removal of AA from hepatic circulation is usually expressed relative to the amounts
absorbed from the portal drained viscera (PDV), and it is important to note that the PDV
includes the whole gastrointestinal tract, pancreas, and spleen. This is critical to note,
because only a small portion of the AA in the portal vein actually comes from first pass
absorption from the small intestine (Lobley and Lapierre, 2003). Similar to studies on the
metabolism of AA in the small intestine, results on the uptake of AA by the liver are
mixed. Variation in the uptake of AA by the liver is influenced by many factors,
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including the nutrient profile of the ration being fed and the physiological state of the
animal (Lobley and Lapierre, 2003). Some of this variation can also be attributed to the
long-standing question of whether the liver acts as a “controller” and regulates the
amount of AA that reaches peripheral tissues or whether the liver act as a “responder”
and removes the AA that are not used by the peripheral tissues (Lobley and Lapierre,
2003). Another big factor influencing AA uptake by the liver is the type of AA being
absorbed (EAA vs. non-essential AA (NEAA), for example).
Essential AA tend to have different removal rates in the liver when compared with
NEAA, and even some EAA, such as branched chain amino acids (BCAA), have
different removal rates when compared with other EAA. Bequette et al. (2003) reported
in dry dairy cows 0 to 30% of absorbed BCAA are removed across the liver, and in
lactating dairy cows there is actually a net release of BCAA from the liver. This coincides
with the findings of Blouin et al. (2002) who also recorded a net positive release of
BCAA from the liver. Lobley (1992) proposed BCAA catabolism in the liver is very
limited and once this threshold is reached, the removal of BCAA by the liver will stop,
and catabolism of BCAA will occur in non-hepatic tissues. Concerning all other EAA,
the amounts removed by the liver varies. According to Bequette et al. (2003), 43% of
Met, 50% of phenylalanine, 11% of threonine, and 28% of histidine were removed in the
liver from the net portal supply of AA. Lapierre et al. (2000) reported liver removal rates
of 29% for Met, 64% for phenylalanine, 23% for threonine, and 39% for histidine. Liver
extraction of NEAA tends to be higher than the extraction of EAA (Bequette et al., 2003).
It appears the extraction of NEAA by the liver exceeds that of the extraction of EAA
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because of their role in metabolic functions, such as gluconeogenesis (Hanigan et al.,
2004). No matter the removal rate, AA are removed for a specific purpose, including the
use of Met for multiple functions in the liver.

Liver Utilization of Met
In the liver, Met that is removed from the hepatic blood flow is converted to SAM,
homocysteine, and cysteine via the methylation cycle. Then, SAM is primarily used for
transmethylation, trans-sulfuration, and polyamine synthesis, SAM appears to be second
only to ATP in the number of reactions in which it is a cofactor (Lu, 2000). According to
Mudd and Poole (1975), Met prefers the catabolic pathway of SAM synthesis in the liver,
where up to half of the daily intake of Met is converted to SAM. In the liver, Met and
ATP are converted to SAM with the help of the enzyme Met adenosyltransferase (Mato
et al., 1997). Once the methyl group of SAM is removed in the transmethylation
processes, SAM will then be converted to S-adenosylhomocysteine. The adenosine is
then removed from S-adenosylhomocysteine, resulting in the formation of homocysteine.
From this point, homocysteine can either be transsulfurated to make cysteine or
remethylated back to Met (Loest et al., 2002). Remethylated Met can either enter the Met
cycle again, or it can be exported out of the liver to be used elsewhere.

Physiological Impacts of Met

Methionine is most well known for its potential impact on milk and milk component
production, but Met can also have a large impact on cow health through its role in liver
lipoprotein synthesis, as a substrate for antioxidant reactions, and for its role in immune
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function (Osorio et al., 2013). The effects on health because of Met supplementation
appear to be most pronounced and beneficial in transition cows and is an essential
nutrient for transition cows (Sun et al., 2016). The term transition refers to the 3 wks.
before calving and the 3 wks. after calving. During this time, cows are much more
susceptible to fatty liver disease, ketosis, retained placenta, hypocalcemia, clinical
mastitis, and displaced abomasum (Sun et al., 2016). Cows are highly susceptible to these
metabolic disorders at this time for a variety of reasons, one of which being the rapid
growth of the fetus prior to parturition and the rapid increase in milk production
postpartum. This rapid increase in milk production creates a high demand for energy
which usually cannot be met with the limited DMI of fresh cows, and then results in a
negative energy balance. This unique problem demands innovative ways of
supplementing and feeding cows in such a way as to increase their profitability and
viability during this stressful transition period. Methionine supplementation may alleviate
some of the problems associated with the transition period.
The synthesis of SAM from Met plays a central role in the health of transition cows;
SAM is a very important methyl donor in the formation of phosphatidylethanolamine to
phosphatidylcholine, which is important in the packaging of VLDL (Osorio et al., 2014).
This is significant in transition cow health, because when transition cows are in a
negative energy balance state, they mobilize their body fat reserves to meet their high
energy demand. As body fat is mobilized, non-esterified fatty acids (NEFA) are formed
and sent to the liver where they can be re-esterified to form triglycerides (Gross et al.,
2013). Choline, which is synthesized from Met, facilitates the movement of NEFA to the
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liver (Goselink et al., 2013). Triglycerides can be carried out of the liver through VLDL,
or they can be stored in the liver, which is a cause of fatty liver disease. Sun et al. (2016)
observed an increase in NEFA concentrations in postpartum transition cows
supplemented with RPMet. The same study reported an increase in plasma VLDL
concentrations, suggesting that Met influences liver lipid metabolism and exportation
(Sun et al., 2016). Methionine can also have a variety of other effects on the health of
transition cows as well.
It has been proposed that Met supplementation can have an impact on the proliferation
of T lymphocyte production. For example, Soder and Holden (1999) reported an increase
in T lymphocyte concentrations when 15 and 30 g/d of RPMet was supplemented to midlactation dairy cows. In comparison, Osorio et al. (2013) reported a tendency for an
increase in phagocytosis in cows supplemented with RPMet. The mechanism behind the
increase in T lymphocyte concentrations and phagocytosis is not well understood, but it
underlines the fact that Met supplementation potentially can have an impact on the
immune function of cows. Methionine supplementation has also been shown to
counteract the negative inflammatory effects of parturition. Osorio et al. (2013) observed
an increase in albumin in Met supplemented cows when compared to control cows.
Decreased albumin concentrations in control cows not supplemented with Met is
understandable, because the lack of albumin is indicative of inflammatory conditions in
transition cows. Methionine supplementation appears to negate some of the effects of
inflammation in transition cows. Methionine can also potentially help in the antioxidant
capacity of transition cows. Glutathione is a product of the methionine cycle in the liver
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and also acts as the primary antioxidant defense in the prevention of oxidative liver injury
(Halsted, 2013). Supplementation of RPMet has been shown to increase and expedite the
synthesis of glutathione, which in theory would affect the antioxidant status of the
transition cow (Osorio et al., 2014). Because of the role of Met in the liver, in lipoprotein
synthesis, as a substrate for antioxidant reactions, and for its role in immune function, it
can be very beneficial to the health of the transition cow.

Conclusions

Methionine has long been recognized as a limiting AA for milk protein synthesis and
milk production (Schwab et al., 1976). In order to meet the Met requirements of the
lactating dairy cow, many different methods have been utilized to deliver useable Met to
the dairy cow. These methods include protecting Met from ruminal degradation or
utilizing Met analogues. A new approach to delivering useable Met to the dairy cow is
the utilization of Met derivatives. A Met derivative is a free Met molecule that contains a
chemical blocking group added to the α-amino group or a Met molecule in which the
acetyl group has been modified (Schwab and Ordway, 2003). The Met derivative that is
the focus of this study is NALM. Acetylated AA may be an effective way of delivering
bioavailable Met to the small intestine where it is absorbed and utilized. This study will
present the impacts of NALM on the lactational and physiological performance of eight
mid to late lactation cows.
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MATERIALS AND METHODS

The dairy cows used in the present study were cared for according to the Live Animal
Use in Research Guidelines of the Institutional Animal Care and Use Committee at Utah
State University. The study was conducted at the Caine Dairy Research Center
(Wellsville, UT), Utah State University from January 25, 2016 to April 18, 2016.

Cows, Experimental Design, and Dietary Treatments
Eight multiparous lactating Holstein cows were used during this trial. At the onset of
the trial the cows averaged 124 ± 13.0 DIM with an average BW of 694 ± 39.7 kg and
757 ± 55.5 kg at the end of the trial.
A double 4 × 4 Latin square design was utilized in this experiment. The duration of
the trial was 84 d which consisted of 4 periods of 21 d each (14 d of treatment adaption
and 7 d of data collection and sampling). Within each square, cows were randomly
assigned to a sequence of four diets during each of the periods. The four dietary
treatments included 0 (control), 15, 30, and 45 g/d/cow of NALM supplementation. In a
previous study done by our group (Fagundes et al., 2016), the same NALM product was
added at a rate of 0.13% DM, to provide approximately 15.7 g/d/cow of available Met. In
the current study, we included half (low dose) and double the previous dose to test if the
NALM supplementation would have a linear and/or a quadratic effect on production as
well as ruminal fermentation parameters. Metabolizable Met and Lys concentrations and
Lys:Met ratios were estimated using the CPM dairy ration analyzer program. The
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experimental NALM product was top-dressed onto each of the diets supplemented with
15, 30, and 45 g/d/cow of NALM.
A developmental NALM product from CJ CheilJedang (Seoul, South Korea) was used
as the supplemental source of RPMet in this study. The NALM product was in powder
form, and its Met concentration was reported to be 78.0%, 67% bioavailable, with 99.5%
purity and 20-30 wt % solubility in water.
Diets were formulated based on NRC (2001) guidelines to ensure sufficient net energy
for lactation (NEL), MP, vitamins, and minerals for production of 40 kg/d of milk with
3.5% fat and 3.0% true protein. Average dietary forage-to-concentrate ratios of 54:46
(DM basis) utilized in this trial were similar to that of a typical high-producing dairy
ration in the Intermountain West (i.e., Utah, Idaho, Wyoming, Montana, and parts of
Arizona and Nevada). Experimental diets consisted of good quality AH with a chemical
composition of 21.4, 32.8, and 24.2% DM for CP, NDF, and ADF, respectively, whereas
CS contained 8.51, 44.4, and 24.0% DM for CP, NDF, and ADF, respectively. AH and
CS accounted for 47 and 46%, respectively, of total forage in the diet.
Cows were housed individually in tie stalls fitted with rubber mattresses covered with
straw and allowed free access to water. Cows were fed twice daily for ad libitum intake at
a level of 110% of expected daily intake with 70% of allotted feed fed at 0600 h and 30%
fed at 1500 h. Feed offered and refused was recorded daily and samples were taken
during the sampling week to determine DMI.
Cows were milked twice daily at 0400 and 1600 h, and milk production was recorded
throughout the entire experiment. Milk was sampled for 2 consecutive d (d 17 and 18)

43
during the a.m. and p.m. milkings during each period. Individual milk samples were
analyzed by the Rocky Mountain DHIA Laboratory (Wellsville, UT) for fat, TP, lactose,
and milk urea nitrogen (MUN). Milk composition was expressed on weighted milk yield
of a.m. and p.m. samples. Milk fat and TP yields were calculated by multiplying milk
yield from the respective day by fat and TP concentration of the milk from an individual
cow. To convert milk TP to milk N, a conversion factor of 6.38 was used (DePeters and
Cant, 1992), and total milk N (kg/d) was calculated as milk TP/6.38 + MUN, where milk
TP and MUN were expressed as kg/d.
All cows were weighed on the first 2 d of the trial (d 1 and 2) and on the last 2 d of
each period (d 20 and 21) after the a.m. milking and before the a.m. feeding. These
weights were used to calculate the mean BW of cows for each experimental period.
Energy partitioning was determined using the data of milk yield, milk composition, and
BW of experimental animals. Energy utilization was determined by calculating energy
for maintenance as BW0.75 × 0.08 (NRC, 2001). Energy of BW change was assumed to be
5.114 Mcal/kg of gain or 4.924 Mcal/kg of loss (NRC, 2001). Milk energy was calculated
as (0.0929 × milk fat concentration) + (0.0563 × milk TP concentration) + (0.0395 × milk
lactose concentration) (NRC, 2001). Estimated NEL value was calculated by total net
energy utilization (maintenance, BW gain, and milk) divided by DMI (Neal et al., 2014).

Feed Sampling and Analysis
Samples of AH, oat hay, and CS were pulled weekly and composited for the duration
of each period to determine DM, and diets were adjusted accordingly to account for any
change in DM concentrations. On d 15 to d 21 of each period, samples of total mixed
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rations (TMR) and orts were collected from individual cows. All samples were frozen
directly after they were pulled and remained frozen until processing. At the end of each
period, all samples were dried at 60°C for 48 h, ground to pass a 1-mm screen (standard
model 4; Arthur H. Thomas Co., Swedesboro, NJ), and stored for chemical analysis. The
DM concentrations of samples were used to calculate intakes of DM and nutrients.
Analytical DM concentration of samples was determined by oven drying overnight at
105°C, and organic matter (OM) was determined by ashing at 550°C for 5 h (AOAC,
2000; method 942.05). Concentration of CP was determined using an automated N
combustion analyzer (Elementar, Analysensysteme GmbH, Hanau, Germany; AOAC,
2000; method 968.06). Concentrations of NDF and ADF were sequentially determined
using a fiber analyzer (200/220, ANKOM Technology, Macedon, NY) according to the
methodology supplied by the company, which is based on the methods described by Van
Soest et al. (1991). Sodium sulfite was used in the procedure for NDF determination and
pre-treated with heat-stable amylase (Type XI-A from Bacillus subtilis; Sigma-Aldrich
Corporation, St. Louis, MO). Ether extract was measured using a fat analyzer (XT20,
ANKOM Technology; AOAC, 2000; Method 2003.05).

Ruminal Fermentation Characteristics
Ruminal fluid samples were collected on d 15 and d 19 at 4 h after the morning
feeding during each period using a Geishauser probe. The fluid was collected with a
solid, tube-like probe with rows of small holes on the end (Geishauser, 1993). To avoid
any possible contamination from saliva, the first 100 mL of ruminal fluid extracted was
discarded, and the next 15 mL was kept for analysis and strained through a polyester
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screen (pore size 355 µm; B & S H Thompson, Ville Mont-Royal, QC, Canada).
Immediately upon extraction from the rumen, the pH of the ruminal fluid was measured
using a portable pH meter (Oakton pH 6; Oakton Instruments, Vernon Hills, IL). Five mL
of the filtered ruminal fluid were mixed with 1 mL of 1% sulfuric acid and stored frozen
(−40°C) for analysis of ammonia-N (NH3-N). Concentration of NH3-N in the ruminal
contents was determined as described by Rhine et al. (1998), using a plate reader (MRXe;
Dynex Technologies Inc., Chantilly, VA). Another 5 mL of filtered ruminal fluid was
added to 1 mL of 25% meta-phosphoric acid, and then stored at −40°C for determination
of volatile fatty acid (VFA) content. Ruminal VFA were separated and quantified using a
gas chromatograph (Model 5890, Hewlett-Packard Lab, Palo Alto, CA) with a capillary
column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZB-FAAP; Phenomenex
Inc., Torrance, CA) and flame-ionization detection. The oven temperature was held at
170°C for 4 min, increased to 185°C at a rate of 5°C/min, then increased by 3°C/min to
220°C, and held at this temperature for 1 min. The injector and the detector temperatures
were 225 and 250°C, respectively, and the carrier gas was helium (Eun and Beauchemin,
2007).

Urine Sampling and Analyses
On d 15, d 16, and d 18, spot urine samples were collected at 0600 and 1800 h from
each cow. Each period, 6 samples of urine were collected from each cow, and after each
sample was collected it was acidified to pH < 4.0, stored at −40°C, and composited by
cow per period. At a later date the samples were thawed in preparation for analysis and
diluted with 39 parts diluent to 1 part urine. The diluent utilized consisted of 0.202%
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sodium 1-heptane sulfonic acid and 0.086% ammonium dihydrogen phosphate
(NH4H2PO4). The solution was brought to a pH of 2.1 using 4 M HCl. Utilization of the
ratio of the urinary purine derivatives (PD) to creatinine is an accepted way to estimate
the microbial protein (MCP) flow to the duodenum (Shingfield and Offer, 1998). The PD
and creatinine were analyzed using an HPLC instrument (Waters Corp., Milford, MA)
according to the procedures set forth by Shingfield and Offer (1998). In order to estimate
urine volume, creatinine was used as a marker (Valadares et al., 1999), and an average
creatinine output of 28 mg/kg of BW as estimated by Whittet (2004) was assumed.
Similar creatinine outputs have been reported (25 to 30 mg/kg of BW daily) (McCarthy et
al., 1983; Jones et al., 1990). In order to estimate the relative differences in MCP
production, the ratio of urinary PD (allantoin and uric acid) to creatinine was used
(Shingfield and Offer, 1998), and the supply of MCP was estimated based on estimates of
urinary excretion of PD according to the method of Chen and Gomes (1992) and Janicek
et al. (2008). In addition to MCP estimations, urinary-urea N was assayed using the
Stanbio Urea Nitrogen Kit 580 (Stanbio Laboratory, Inc., San Antonio, TX) according to
the instructions provided.

Blood Sampling and Analyses
Blood was drawn from the coccygeal artery or vein into serum and whole blood
vacuum collection tubes on d 15, d 16, and d 19 at 0 h prior to a.m. feeding and on d 19
and d 20 at 4 and 8 h after a.m. feeding. Blood was drawn for analyzing the
concentrations of beta-hydroxybutyrate (BHB), glucose, NEFA, blood AA, and blood
urea nitrogen (BUN). Immediately after drawing blood, BHB concentration was
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measured using a handheld electronic BHB meter and test strips (Precision Xtra, Abbott
Diabetes Care, Abingdon, UK) according to Iwersen et al. (2009). The BHB values were
multiplied by 10.3 to convert from mmol/L to mg/100 mL (Oetzel and McGuirk, 2007).
Similar to BHB, blood glucose was measured and recorded immediately after blood was
drawn using a handheld electronic glucometer and glucose test strips (Precision Xtra).
After sampling, blood samples were immediately transported on ice to the laboratory for
further processing. Samples were centrifuged at 2,300 × g for 20 min, and serum was
then collected and stored at −40°C. At the end of the trial, serum samples were sent off to
the Animal Health Diagnostic Center, Cornell University (Ithaca, NY) for NEFA and
BUN analysis, and the remaining serum samples were kept for AA analysis.
Serum samples were prepared for AA analysis using the EZ:faast GC-FID Free
(Physiological) Amino Acid Analysis Kit (Phenomenex Inc., Torrance, CA).
Concentrations of plasma free AA were determined in accordance with the user manual
provided with the kit. Extraction of free AA from the plasma consisted of a combination
of solid-phase extraction, derivatization, and liquid/liquid extraction. The organic phase
containing the AA in question was analyzed using a GC (Model 5890, Hewlett-Packard
Lab) with a capillary column (30 m × 0.32-mm i.d., 1-μm phase thickness, Zebron ZBFAAP; Phenomenex Inc., Torrance, CA) and flame-ionization detection.

Statistical Analysis
Analysis of variance was conducted using the MIXED procedure (Littell et al., 1998)
of SAS (SAS Institute, 2016) for all the statistical analyses. The model included effects of
square, dietary treatment, day, and interactions among the fixed effects, with cow within
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square and period within square designated as random variables. The effect of day was
included as a fixed repeated measurement. Simple, autoregressive one, and compound
symmetry covariance structures were used in the analysis depending on low values for
the Akaike’s information criteria and Schwartz’s Bayesian criterion. The relationship
between N intake and N excretions into milk, urine, and feces was determined by linear
regression using the PROC REG procedure of SAS. For all analyses, degrees of freedom
were estimated with the Kenward-Roger specification in the models. Means were
separated by use of orthogonal polynomial contrasts: 1) control vs. NALM treatments, 2)
linear effect of increasing NALM, and 3) quadratic effect of increasing NALM. Least
square means were reported throughout. Treatment effects were declared significant if
P ≤ 0.05, and differences were considered to indicate a trend toward significance if
0.05 < P ≤ 0.10.
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RESULTS AND DISCUSSION

Characteristics of Experimental Diets
Ingredient and chemical composition of experimental diets are presented in Table 1.
All diets supplied NEL in excess of requirement (NRC, 2001). Mean concentrations of
NDF, ADF, starch, ether extract, and non-fiber carbohydrates (NFC) were similar for all
treatments. As expected, CP concentrations did not increase with NALM
supplementation due to the top-dressing application onto the basal TMR.
Supplementation of NALM at varying doses tested in the current trial resulted in 7.84,
15.7, and 23.5 g/d/cow of absorbable Met in the diet in addition to the 54.9 g/d of
absorbable Met from the basal TMR, which resulted in total absorbable Met amounts of
62.7, 70.6, and 78.4 g/d/cow in the rations supplemented with 15, 30, and 45 g/d of
NALM, respectively. The amount of total absorbable Met in the respective rations
compared to amounts of MP led to concentrations of 1.95, 2.22, 2.50, and 2.77% of MP.
Ideal concentrations of Met that are needed in MP for maximum milk protein yield have
been reported to be 2.4% by NRC (2001) and 2.5% by Doepel et al. (2004). Comparing
metabolizable Lys to metabolizable Met led to Lys:Met of 3.43:1, 3.00:1, 2.67:1, and
2.40:1 for rations supplemented with 0, 15, 30, and 45 g/d of NALM, respectively.
Optimal metabolizable Lys:Met for maximum milk and milk protein yield have
traditionally been reported as a 3.00:1 (NRC, 2001, Whitehouse et al., 2009), but very
recently optimal ratios as low as 2.69:1 were reported by Van Amburgh et al. (2015) after
calculating the optimum efficiency of use for Lys and Met using data derived from a
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Table 1. Ingredients and chemical composition of the experimental diets with varying doses of N-acetyl-L-Met (NALM) supplemented to mid to late lactating Holstein dairy cows
Diet
Item
0 g/d NALM
15 g/d NALM
30 g/d NALM
45 g/d NALM
Ingredient, % of DM
Alfalfa hay
25.0
25.0
25.0
25.0
Oat hay
3.76
3.75
3.75
3.75
Corn silage
24.9
24.8
24.8
24.8
Beet pulp
3.02
3.01
3.01
3.01
Cottonseed
4.89
4.88
4.88
4.88
Corn, steam-flaked
19.9
19.9
19.9
19.9
Corn grain, high-moisture
3.67
3.66
3.66
3.66
Canola meal
5.88
5.87
5.87
5.87
Soybean meal
5.88
5.87
5.87
5.87
NALM1
0.00
0.06
0.11
0.17
2
Fat supplement
0.49
0.49
0.49
0.49
Sodium bicarbonate
0.58
0.58
0.58
0.58
Vitamin and mineral mix3
2.03
2.03
2.03
2.03
Chemical composition, % of DM
DM, %
58.3 ± 1.08
58.3 ± 1.42
58.4 ± 1.23
58.7 ± 1.68
OM
89.3 ± 0.79
90.0 ± 0.73
89.8 ± 0.77
90.1 ± 0.59
CP
17.3 ± 0.70
16.7 ± 0.85
17.7 ± 1.12
17.1 ± 1.16
4
RDP
11.1
11.1
11.2
11.2
RUP4
6.19
6.20
6.26
6.28
NDF
30.6 ± 2.40
31.8 ± 2.21
30.3 ± 1.72
30.2 ± 1.16
ADF
18.3 ± 2.00
19.1 ± 1.74
17.8 ± 1.53
18.3 ± 1.20
Starch
20.2 ± 1.25
20.8 ± 1.08
19.3 ± 1.36
20.2 ± 0.95
Ether extract
1.95 ± 0.842
2.18 ± 0.219
1.73 ± 0.563
1.82 ± 0.572
NFC5
39.2 ± 1.72
39.3 ± 1.60
40.1 ± 0.87
41.0 ± 1.86
4
NEL, Mcal/kg
1.55
1.55
1.55
1.55
table continues
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Absorbed MetTMR,6 g/d
54.9
54.9
54.9
54.9
7
Absorbed MetNALM, g/d
0.00
7.84
15.7
23.5
Total absorbed Met,8 g/d
54.9
62.7
70.6
78.4
4
Absorbed Lys, g/d
188.3
188.3
188.3
188.4
Metabolizable Lys,9 % of MP
6.68
6.67
6.67
6.66
Metabolizable Met,10 % of MP
1.95
2.22
2.50
2.77
11
Lys:Met
3.43:1
3.00:1
2.67:1
2.40:1
1
Developmental NALM product made by CJ CheilJedang Co. (Seoul, Korea).
2
Calcium salts of palm oil (EnerGII®, Virtus Nutrition, LLC, Corcoran, CA).
3
Formulated to contain (per kg DM): 226.7 mg of Se (from sodium selenite), 9278.7 mg of Cu (from copper amino acid complex),
40,537.4 mg of Zn (from zinc amino acid complex), 38,653.4 mg of Mn (from manganese amino acid complex), 552.6 mg of Co
(from cobalt carbonate), 1,234,585.2 IU of vitamin A, 152,808.1 IU of vitamin D, 3,815.1 IU of vitamin E, and 295 mg of Rumensin
(Elanco Animal Health, Greenfield, IN).
4
Based on tabular value (NRC, 2001).
5
NFC = 100 – CP – NDF – ether extract – ash.
6
Estimated using NRC (2001) for basal TMR without NALM supplementation.
7
Estimated supply of absorbed Met from NALM product (assuming 78% Met content and 67% bioavailability).
8
Total absorbed Met = absorbed MetTMR + absorbed MetNALM.
9
Metabolizable Lys = absorbed Lys/MP supply.
10
Metabolizable Met = total absorbed Met/MP supply.
11
Lys:Met = metabolizable Lys/metabolizable Met.
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meta-analysis of 40 published papers (Doepel et al., 2004) and a trial performed by
Lapierre et al. (2007).

Feed Intake and Productive Performance
Increasing NALM supplementation linearly increased intakes of DM and CP with a
trend toward a linear increase in ADF intake (P = 0.09) but no effect on NDF intake
(Table 2). The increase in DMI was unexpected, because little evidence exists to suggest
that an increase in AA supplementation has any effect on DMI in dairy cows (Allen,
2000). Similarly, Kung and Rode (1996) stated that in general, RPAA supplementation
did not improve DMI, which corresponds to the findings of other studies performed by
Leonardi et al. (2003) and Chen et al. (2011). In contrast, a limited number of studies
(Broderick et al., 2009; Zanton et al., 2014) have shown an increase in DMI with RPMet
supplementation, while Ordway et al. (2009) and Zanton et al. (2014) reported decreases
in DMI. Intake of DM generally can increase or decrease for a number of factors,
including animal factors, management, climatic conditions, and dietary composition
(Hayirli et al., 2002). For example, decreases in DMI upon supplementation of RPMet
have been correlated with excessive concentrations of Met (Robinson et al., 2000), the
presence of co-limiting AA (Patton, 2010), and the sulfur smell of RPMet products
(Benefield et al., 2009), while increases in DMI upon RPMet supplementation have been
associated with dietary increases in CP (Broderick et al., 2009), parity (Ordway et al.,
2009), and the type of RPMet product utilized (Zanton et al., 2014). Supplementation of a
Met analogue, HMBi, has also increased DMI (Osorio et al., 2014) because of the
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Table 2. Intake of DM and nutrients and productive performance of mid to late lactating Holstein dairy cows supplemented with varying doses of N-acetyl-L-Met (NALM)
NALM
Contrast1
Item
0 g/d
15 g/d
30 g/d
45 g/d
SEM
NALM
L
Q
Intake, kg/d
DM
29.0
29.4
30.5
31.7
1.14
0.04
< 0.01
0.57
CP
4.98
4.85
5.44
5.44
0.253
0.02
< 0.01
0.65
NDF
8.89
9.30
9.31
9.54
0.384
0.44
0.14
0.76
ADF
5.32
5.57
5.50
5.79
0.249
0.26
0.09
0.89
Yield, kg/d
Milk
38.0
37.4
37.7
38.7
2.90
0.18
0.17
0.07
3.5% FCM
38.9
38.2
37.8
38.5
2.87
0.45
0.48
0.72
ECM
38.4
38.8
38.4
39.2
2.82
0.49
0.73
0.16
Milk composition, %
Fat
3.64
3.60
3.54
3.44
0.167
0.10
0.02
0.54
True protein
3.13
3.13
3.14
3.09
0.084
0.68
0.43
0.36
Lactose
4.76
4.75
4.74
4.78
0.057
0.55
0.76
0.21
Milk component yield, kg/d
Fat
1.39
1.36
1.32
1.35
0.110
0.27
0.16
0.26
True protein
1.18
1.16
1.19
1.21
0.078
0.28
0.10
0.29
Lactose
1.82
1.78
1.79
1.86
0.152
0.12
0.19
0.03
Dairy efficiency
Milk yield/DMI
1.31
1.26
1.23
1.22
0.078
0.30
0.07
0.66
3.5% FCM yield/DMI
1.34
1.30
1.25
1.22
0.078
0.23
0.05
0.93
ECM yield/DMI
1.35
1.32
1.26
1.24
0.075
0.12
0.02
0.84
1
NALM = control (0 g/d) vs. NALM treatments; L = linear effect of increasing NALM; Q = quadratic effect of increasing NALM.
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potential stimulatory effect of HMBi on cellulolytic bacteria and the subsequent increase
in passage rate and DMI (Lee et al., 2015b). In the current study, it appears that NALM
supplementation may have had a similar effect by stimulating MCP synthesis, thus
increasing passage rate and subsequently increasing DMI, which will be discussed in
more detail later in this paper.
In spite of the linear increase in DMI with increasing NALM supplementation, milk
production did not follow the same pattern (Table 2). Supplementation of NALM tended
(P = 0.07) to have a quadratic effect on milk yield, as the greatest NALM
supplementation (45 g/d) increased milk yield, but not at 15 and 30 g/d NALM compared
with control. Supplementing NALM did not affect yields of 3.5% FCM and ECM
regardless of dose rate. Similar to the present study, multiple studies investigating RPMet
have shown similar results of little to no change in milk yield (Leonardi et al. 2003;
Rulquin et al., 2006). Patton (2010) found that many different factors affect the efficacy
of RPMet on milk yield, including the presence of co-limiting AA, the severity or lack of
Met deficiency in the ration, breed, type of forage fed, and stage of lactation. In the
current study, stage of lactation appeared to be the main factor that interfered with milk
yield, because cows that are in mid to late lactation generally tend to lack the hormonal
drive necessary to increase milk yield (Oltenacu et al., 1980; Penasa et al., 2016) and,
therefore, supplementation of NALM may be ineffective at increasing milk yield when
supplemented in mid to late lactation cows.
Supplementation of NALM had no effect on milk true protein and lactose
concentrations, but had a negative linear effect on milk fat concentration (Table 2). No
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changes were recorded in milk fat yield, whereas milk protein yield tended to increase
linearly (P = 0.10) with increasing NALM supplementation. RPMet has long been
promoted as an effective way to increase milk protein concentration and yield, and many
studies have shown increases in milk protein concentration and yield when RPMet has
been supplemented (Ordway et al., 2009; Patton, 2010; Osorio et al., 2013). For example,
Rulquin et al. (2006) reported a linear increase in milk protein yield (962 to 1,003 g/d)
and Wang et al. (2010) reported a linear increase in milk protein yield (870 to 920 g/d)
upon supplementation of RPMet. Feed efficiencies based on yields of milk and 3.5%
FCM tended to decrease (P = 0.07 and 0.05, respectively), while feed efficiency based on
ECM yield decreased linearly, because ECM yield did not increase in relation to the
increase in DMI. This is a significant parameter, as it helps define the efficiency and
productivity of a dairy herd in converting feed inputs into saleable outputs. The linear
decrease in feed efficiency (milk yield/DMI) from 1.31 to 1.22 coupled with increasing
NALM supplementation in our study is below the average feed efficiency of 1.36
reported by Britt et al. (2003). Although some production parameters in the current study
increased, the decrease in feed efficiency suggests that NALM supplementation in mid to
late lactation cows may not be economically beneficial when looking only at production
parameters.

Change of BW and Net Energy Utilization
No changes were seen in BW gain with supplementation of NALM (Table 3).
However, there was a numerical increase (0.72 to 1.04 kg/d) in BW gain seen when
comparing the control diet to the diet supplemented with 45 g/d of NALM, which
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Table 3. Change of BW and net energy utilization of mid to late lactating Holstein dairy cows supplemented with varying doses of Nacetyl-L-Met (NALM)
NALM
Contrast1
Item
0 g/d
15 g/d
30 g/d
45 g/d
SEM
NALM
L
Q
BW
Initial, kg
724
726
724
714
16.4
0.47
0.21
0.29
Mean, kg
739
732
744
736
16.5
0.18
0.77
0.95
Gain, kg/d
0.72
0.30
0.97
1.04
0.372
0.31
0.21
0.40
Calculated net energy values,
Mcal/d
Maintenance
11.3
11.3
11.4
11.3
0.22
0.11
0.44
0.67
BW gain
2.93
2.50
5.77
4.68
1.826
0.40
0.22
0.82
Milk
26.3
26.0
25.5
26.2
1.63
0.42
0.64
0.17
BW gain + milk
29.3
27.9
32.0
31.6
2.62
0.37
0.19
0.79
2
Total
40.6
39.2
43.4
42.9
2.67
0.35
0.19
0.80
NEL,3 Mcal/kg of DMI
1.40
1.36
1.41
1.36
0.076
0.77
0.73
0.92
Net energy partitioning,
% energy intake
Maintenance
29.0
29.6
26.3
27.1
1.69
0.16
0.09
0.93
BW gain
5.92
5.56
13.1
9.15
3.73
0.29
0.21
0.56
Milk
65.3
66.0
59.2
62.3
3.25
0.18
0.15
0.60
BW gain + milk
71.0
70.4
73.7
72.9
1.69
0.16
0.09
0.93
1
NALM = control (0 g/d) vs. NALM treatments; L = linear effect of increasing NALM; Q = quadratic effect of increasing NALM.
2
Net energy used for maintenance, BW change, and milk.
3
Calculated NEL = calculated total net energy, Mcal/d ÷ DMI (kg/d).
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suggests that supplementation of NALM may have played a role in BW gain. Information
concerning the effects of RPMet supplementation on BW gain in ruminants is lacking,
but some studies have reported increases in BW gain upon RPMet supplementation
(Deetz et al., 1985; Oke et al., 1986). Due to the chemical makeup of NALM (an acetyl
group and a Met molecule), it would stand to reason that supplementation of NALM may
potentially have an impact on BW gain. It is well understood that Met is a limiting AA
for growing cattle (Richardson and Hatfield, 1978) and, therefore, an increase in
available Met will aid in protein deposition in the body (Loest et al., 2002). The role of
Met in the formation of phospholipids through conversion of Met to SAM will also aid in
fat deposition in growing cattle (Obeid and Herrmann, 2009). In addition, acetate is also
recognized for its role as a carbon source for fat synthesis (Bauman and Griinari, 2001).
The small number of animals (n = 8) utilized in this study may account for the lack of a
significant effect on BW gain witnessed; however, understanding the energy partitioning
of lactating dairy cows may help highlight the importance of the numerical increase in
BW gain observed in the current study.
Supplementation of NALM did not influence net energy partitioning as a percentage
of energy intake of BW gain and milk yield (Table 3). However, there was a numerical
increase in the proportion of energy intake that was partitioned to BW gain where
supplementation of NALM increased the percentage of energy intake partitioned to BW
gain from 5.92% in the control diet to 9.15% in the diet supplemented with 45 g/d of
NALM. The numerical increase in the percentage of energy intake that was partitioned to
BW gain tended to have an effect on increasing the net energy partitioning toward BW
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gain and milk yield combined (P = 0.09). The net energy consumed by a dairy cow can
be utilized and partitioned to one of three physiological processes, maintenance, growth,
and lactation. The efficiency at which each physiological process operates is different,
and the partitioning of nutrients to each of these processes changes throughout lactation,
as can be seen in a normal lactation cycle where milk production, DMI, and BW gain
follow a curvilinear pattern (NRC, 2001). During a normal lactation cycle, DMI will lag
behind milk production until maximum milk production is reached, at which point DMI
will continue to increase for a period of time and then decrease in the same pattern as
milk production (NRC, 2001). When the energy necessary for milk production can be
obtained through feed intake alone, the lactating dairy cow will stop mobilizing body fat
and protein reserves and begin to partition energy toward BW gain (Kirkland and
Gordon, 2001). Kirkland and Gordon (2001) stated that this curvilinearity may be
explained by the increased partitioning of nutrients and energy from milk production to
BW gain. Therefore, it may be inferred that any influence on DMI in mid to late lactating
dairy cows will have an effect on energy partitioning. Vandehaar and St-Pierre (2006)
stated that either changes in diet composition or DMI can influence the partitioning of
energy and nutrients from the mammary gland to other body tissues. For example, a study
using mid lactation cows (70 ± 7 DIM) fed high-grain, low-fiber diets reported an
increase in energy intake (10%) with most of that energy being partitioned toward BW
gain rather than milk yield (Oba and Allen, 2000). As reported earlier, DMI in the current
study linearly increased with increasing NALM supplementation, possibly explaining the
effect on net energy partitioning to both BW gain and milk production.
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Stage of lactation also plays a major role in energy and nutrient partitioning. For
instance, in early lactation, high-producing dairy cows partition 90 to 430 g/d of AA from
tissue protein reserves to counteract the deficiency in ingested AA (Bequette et al., 2003).
Later in lactation due to tissue sensitivity and substrate supply, an equivalent amount of
AA will be partitioned back to the tissue protein reserves to replenish the loss accrued in
early lactation (Bequette et al., 2003). Utilizing multiple regression analysis, Burt (1957)
reported that only milk yield drove the partitioning of energy and nutrients, whereas
Coulon and Remond (1991) and Kirkland and Gordon (2001) found that both DIM and
milk yield directed the partitioning of energy and nutrients. Both increasing DIM and
diminishing milk yield throughout the current study in mid to late lactation appear to
have likely influenced the energy and nutrient partitioning of dairy cows when
supplemented with NALM, channeling more energy into BW gain and, therefore,
impacting the combined energy proportioned to BW gain and milk production.
Regardless of the mechanism behind the partitioning of net energy and nutrients to both
BW gain and milk production, an effect such as the one seen in the present study would
be beneficial to the modern, high-producing dairy cow. As cows progress later into
lactation, there is a competition for nutrients to be utilized for milk production, BW gain,
and fetus development. Body weight gain is often overlooked, but is a crucial factor
during lactation because it influences the longevity and fertility of high-producing dairy
cows in subsequent lactations (Coffey et al., 2002). Thus, NALM supplementation
appears to be beneficial in aiding mid to late lactating cows partition more energy to both
BW gain and milk production, potentially increasing fertility and longevity. The lack of a
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significant effect seen in the current trial, coupled with the numerical increase seen
suggests more work needs to be done to assess the potential effects of NALM
supplementation.

Utilization of N
As anticipated because of the clear effects seen on DMI, cows fed the rations
supplemented with varying doses of NALM consumed more N than those fed the control
(linear effect; Table 4). A previous study performed by our group (Fagundes et al., 2016)
did not find an increase in N intake upon supplementation of NALM. Traditionally,
supplementation of RPMet products have not been shown to increase N intake because of
the lowered dietary CP concentration in basal diets normally associated with RPMet
supplementation (Leonardi et al., 2003; Broderick et al., 2009). Supplementation of
NALM at varying doses had no effect on milk N excretion in the current study. As a
result of the linear increase in N intake and the lack of response in milk N excretion after
supplementation of NALM, milk N:N intake decreased linearly from 0.25 to 0.23. The N
utilization efficiencies reported in the current study are relatively low compared to the
average efficiencies (25 to 35%) reported in the literature (Chase, 1994; Hristov et al.,
2004) but fall within the normally accepted range (15 to 45%; Dijkstra et al., 2013).
There are multiple studies that collaborate with the results of the current study that
increased N intake decreases N utilization efficiency (Castillo et al., 2000; Kalscheur et
al., 2006; Dijkstra et al., 2013). The lack of response in milk N when NALM was
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Table 4. Utilization of N by mid to late lactating Holstein dairy cows supplemented with varying doses of N-acetyl-L-Met (NALM)
NALM
Contrast1
Item
0 g/d
15 g/d
30 g/d
45 g/d
SEM
NALM
L
Q
N intake, g/d
798
777
871
870
40.4
0.02
< 0.01
0.65
Milk N,2 g/d
197
199
194
196
10.1
0.27
0.29
0.98
3
Milk N:N intake
0.25
0.25
0.23
0.23
0.011
0.04
0.02
0.82
MUN, mg/100 mL
16.2
16.4
15.7
15.5
0.61
0.15
0.04
0.58
BUN, mg/100 mL
18.7
20.5
18.7
18.6
1.32
0.10
0.40
0.10
NH3-N,4 mg/100 mL
19.4
15.4
17.7
16.1
1.80
0.26
0.28
0.42
5
Urinary N excretion, g/d
313
311
304
298
15.7
0.23
0.05
0.70
Fecal N excretion,6 g/d
287
272
370
373
36.8
0.02
< 0.01
0.71
7
Manure N excretion, g/d
600
583
674
670
33.8
0.03
0.01
0.77
1
NALM = control (0 g/d) vs. NALM treatments; L = linear effect of increasing NALM; Q = quadratic effect of increasing NALM.
2
Milk N (kg/d) = milk true protein (kg/d)/6.38 + MUN (kg/d).
3
Efficiency of use of feed N to milk N.
4
Ruminal ammonia-N.
5
Predicted using the equation: 0.026 × MUN, mg/100 mL × BW, kg (Wattiaux and Karg, 2004).
6
Predicted using the equation: N intake, g/d – urinary N excretion, g/d – milk N, g/d.
7
Manure N, g/d = urinary N excretion, g/d + fecal N excretion, g/d.
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supplemented was related to the lack of response in milk production seen in the current
study, suggesting that NALM was utilized elsewhere in the body tissues.
Supplementing NALM did not affect ruminal NH3-N concentration in spite of a
significant increase in N intake by NALM supplementation (Table 4). Ruminal NH3-N
concentration is a result of the balance between production (proteolysis) and assimilation
(De Visser et al., 1997), and thus any efforts to maximize N utilization in the rumen
should involve an optimal balance between the 2 metabolic processes. Yet,
concentrations and components of dietary CP can influence microbial activity, as RDP
supplies peptides, amino acids, and NH3-N derived from microbial proteolysis for use in
microbial protein synthesis (Wallace et al., 1997). Given the fact that greater N input into
the rumen associated with increased N intake as a result of NALM supplementation did
not have an effect on NH3-N concentration, signifies that dietary N utilization in the
rumen may have been manipulated due possibly to a degraded fraction of NALM in the
rumen.
Concentration of MUN linearly decreased with supplementation of NALM (Table 4),
and it ranged from 15.5 to 16.2 mg/100 mL, which is higher than the accepted, optimal
range of 10 to 14 mg/100 mL (Wattiaux et al., 2005), but the slight reduction in MUN
concentration with NALM supplementation (Appendix A) may have a biologically minor
impact. However, it is noteworthy to indicate that the linear increase in N intake with
increasing NALM supplementation did not correspond to MUN concentration.
Supplementation of RPMet has been shown to decrease MUN concentration in multiple
studies (Broderick et al., 2008; Wang et al., 2010; Arriola Apelo et al., 2014), but this
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decrease in MUN concentration was associated with decreased N intake as a result of
decreased CP in the diets supplemented with RPMet. For example, Broderick et al.,
(2008) tested 4 experimental diets with decreasing concentrations of CP (18.6 to 14.8%)
and corresponding increases of supplemental RPMet (0 to 15 g/d). As CP decreased and
RPMet supplementation increased, milk production and N utilization efficiency increased
linearly, N intake decreased linearly, and concentrations of MUN decreased linearly (14.5
to 7.9 mg/100 mL; Broderick et al., 2008). In a different trial in the same study conducted
by Broderick et al. (2008), two levels of CP (17.3 and 16.1%) were tested with either 0 or
10 g/d of RPMet. No effect of RPMet supplementation on MUN was reported (Broderick
et al., 2008). This study collectively suggests that the effectiveness of RPMet would be
minimal on decreasing MUN concentration. Rather, the changes in MUN concentration
was a direct consequence of decreasing concentrations of CP in the diets while
maintaining potential production.
Concentration of BUN showed a tendency to decrease (P = 0.10) in response to
NALM supplementation, and urinary N excretion linearly decreased. Urea N found in
blood, urine, and milk is derived from NH3-N in the rumen and, therefore, the amount of
urea in urine is directly proportional to that of urea in blood which is proportional to
MUN (Jonker et al., 1998). The decrease in urinary N excretion upon increasing
supplementation of NALM in the present study suggests that NALM supplementation
may have improved the AA balance in MP, and thus decreased deamination of absorbed
AA, leading to a decrease in urinary N output (Wang et al., 2010). The linear decrease in
urinary N excretion (Appendix A) with increasing NALM supplementation is impactful,
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because urinary N is the most environmentally volatile form of N excreted (Varel et al.,
1999). Unlike the many factors that affect MUN, BUN, and urinary N, fecal N is directly
correlated with DMI and N intake (Huhtanen et al., 2008). Therefore, because of the
substantial increase in N intake, NALM supplementation linearly increased fecal N
(Appendix A) as well as manure N excretions in our study. Hence, in view of overall
consideration on environmental N management, a partial benefit by decreasing urinary N
output by supplementing NALM would be discounted because of the increased N
excretion in manure.

Ruminal Fermentation Characteristics
Supplementation of NALM had no effect on ruminal pH, which ranged from 6.15 to
6.23 (Table 5). Total VFA concentration was similar across treatments. Except a trend (P
= 0.06) toward a quadratic response on valerate proportion, VFA composition did not
differ among treatments. These results are consistent with other studies; Davidson (2006)
reported minimal effects on ruminal fermentation in continuous cultures receiving RPMet
supplementation because of limited impact on energy metabolism in the rumen from
traditional RPMet products. The current study, along with previous studies, suggest that
the effects of RPMet including NALM on ruminal VFA profiles is minimal.
In spite of the minimal impact on VFA profiles in the rumen, NALM supplementation
linearly increased MCP yield (Table 5). Supplementation of RPMet traditionally has not
had an impact on microbial production, with the exception of Met analogues such as
HMBi because of their ruminal degradability. Several studies have shown positive effects
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Table 5. Ruminal fermentation characteristics of mid to late lactating Holstein dairy cows supplemented with varying doses of Nacetyl-L-Met (NALM)
NALM
Contrast1
Item
0 g/d
15 g/d
30 g/d
45 g/d
SEM
NALM
L
Q
Ruminal pH
6.23
6.15
6.21
6.22
0.066
0.63
0.82
0.31
Total VFA, mM
104
110
102
108
4.1
0.14
0.80
0.93
Individual VFA,2 mM
Acetate (A)
63.3
66.9
63.6
66.7
3.01
0.37
0.43
0.90
Propionate (P)
22.6
23.8
21.3
23.9
1.50
0.33
0.80
0.54
Butyrate
13.0
14.2
13.4
12.9
0.77
0.35
0.66
0.14
Valerate
1.90
2.04
2.01
1.91
0.910
0.27
0.99
0.06
Isobutyrate
1.31
1.27
1.22
1.29
0.125
0.54
0.54
0.25
Isovalerate
1.84
1.75
1.74
1.80
0.167
0.90
0.76
0.50
A:P
2.83
2.71
2.64
2.60
0.185
0.54
0.16
0.77
3
MCP, g/d
1835
1758
1923
1891
78.6
0.02
0.05
0.50
1
NALM = control (0 g/d) vs. NALM treatments; L = linear effect of increasing NALM; Q = quadratic effect of increasing NALM.
2
Expressed as mol/100 mol.
3
Microbial protein production, g/d = ({[purine derivatives production – (0.385 × BW0.75)]/0.85} × 70 × 6.25)/(0.13 × 0.83 × 1,000)
(Janicek et al., 2008).
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of HMB and HMBi supplementation on aspects of ruminal fermentation, including
increases in total concentrations of VFA (Martin et al., 2013), NDF digestion (Noftsger et
al., 2005), and MCP yield (Lee et al., 2015b). It is unclear how NALM supplementation
increased MCP yield in the current study. It has been reported the efficiency of MCP
yield increases when AA or peptides are used as a source of N rather than ammonia
(Maeng et al., 1976). Multiple in vitro studies have shown a positive effect of AA
supplementation on microbial growth (Maeng et al., 1976; Argyle and Baldwin, 1989;
Russell and Strobel, 1993). In vivo studies have also shown similar results (Lundquist et
al., 1985; Rooke and Armstrong, 1989). Studies concerning the effects of Met
specifically on microbial growth are sparse, but it has been reported that rumen microbes
utilize Met for different physiological aspects such as incorporation into cellular material
(Patterson and Kung, 1988) and lipid biosynthesis (Patton et al., 1970). Based on the
aforementioned data, it may be concluded if any amount of NALM was degraded in the
rumen and converted to Met, then the available Met may stimulate MCP production.
A continuous culture study estimated the ruminal protection of NALM to be 67%
(Windschitl and Stern, 1988), which was the same rate we found for the NALM product
used in the current study after a 24-h incubation using an in vitro batch culture incubation
(data not reported). In order for NALM to be degraded or hydrolyzed, the aminoacylase
enzyme needs to be present (Baxter et al., 2001). This enzyme is found in multiple
mammalian tissues (Giardina et al., 1997), but studies involving its presence or lack
thereof in the rumen were not found. It has been reported, however, that certain
microorganisms can produce this enzyme (Tripathi et al., 2000), including bacteria that
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reside in the rumen. Aminoacylase has been purified from Bacillus spp. and
Pseudomonas spp. (Story et al., 2001), which both reside in the rumen. Other rumen
dwelling bacteria such as Aspergillus spp. and Alcaligenes spp., can also produce the
aminoacylase enzyme (Gentzen et al., 1980; Wakayama et al., 1996). There is no in vivo
evidence currently in the literature to validate the in vitro findings. Therefore, more
research needs to be done on the prevalence of the aminoacylase enzyme in the rumen
and the possible effect of its presence on NALM degradation and partial conversion to
Met in the rumen.

Plasma Metabolite and AA Profiles
Supplementation of NALM did not have an effect on plasma concentrations of NEFA,
BHB, and glucose (Table 6), but it led to a trend toward a linear increase in Met (P =
0.08), a linear increase in Gly, and a quadratic increase in Ala concentration. As plasma
Met concentration provides a qualitative measure of the postruminal delivery of Met from
RPMet products (Blum et al., 1999), it is important to note the relationship between
plasma Met concentration and RPMet supplementation. In a study done by Koenig and
Rode (2001), RPMet was supplemented at 20 and 63 g/d, and as expected a 32.5 and
65.5% increase in plasma Met concentration above the control diet (0 g of RPMet) was
observed for the 20 and the 63 g/d RPMet supplemented diet, respectively. The ranges
reported by Koenig and Rode (2001) were similar to the increase in plasma Met
concentration (51 to 71%) the authors reported in the same study when Met was infused
into the duodenum at similar rates. Blum et al. (1999) also reported a linear increase in
plasma Met concentration (16.6 to 144.8 µmol/L) 5 d after supplementation with 60 and
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67 g/d of RPMet products, when compared with plasma Met concentration 3 d before
supplementation. The relatively small increase in plasma Met concentration with NALM
supplementation recorded in the present trial may have occurred because Met
requirements for other physiological functions, such as BW gain, were not met. It is
reported in the literature when available EAA are below their requirement, the plasma
EAA concentrations will either increase marginally or not increase at all (Broderick et al.,
1974; Bergen, 1979; Koenig and Rode, 2001). Very little information exists concerning
the relationship between duodenal AA supply and plasma AA concentrations and the
factors affecting that relationship and the control of the removal of plasma AA (Patton et
al., 2015). Interestingly, Patton et al. (2015) hypothesized that Met supplementation may
stimulate MCP production which in turn would demand more removal of plasma Met,
which supports the increase in MCP production discussed earlier in this paper and may
account for the modest increase in plasma Met concentrations seen in the current study.
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Table 6. Blood chemistry parameters and AA concentrations in plasma of mid to late lactating Holstein dairy cows supplemented with
varying doses of N-acetyl-L-Met (NALM)
NALM
Contrast1
Item, µM
0 g/d
15 g/d
30 g/d
45 g/d
SEM
NALM
L
Q
2
NEFA, mEq/L
0.08
0.09
0.08
0.09
0.008
0.10
0.43
0.79
BHB, mg/100 mL
5.03
4.47
4.71
4.73
0.384
0.25
0.46
0.12
Glucose, mg/100 mL
40.8
41.8
42.2
41.7
1.04
0.34
0.22
0.17
3
EAA
His
63.4
61.6
65.1
65.2
3.09
0.26
0.17
0.53
Ile
104
96.0
102
98.8
5.08
0.13
0.44
0.36
Leu
177
162
177
171
10.5
0.06
0.86
0.35
Lys
87.6
88.7
89.0
86.7
5.68
0.97
0.89
0.65
Met
20.8
22.1
23.0
22.5
0.93
0.09
0.08
0.22
Phe
87.9
78.6
81.0
78.6
3.76
0.20
0.11
0.33
Thr
59.6
57.4
58.5
57.4
3.71
0.78
0.48
0.74
Val
242
231
339
234
53.4
0.38
0.72
0.35
Total EAA
840
795
934
809
57.9
0.26
0.84
0.46
4
NEAA
Ala
172
162
170
177
7.5
0.09
0.22
0.04
Asp
21.9
22.1
22.5
17.7
5.05
0.76
0.46
0.49
Glu
29.9
29.0
33.4
32.4
3.59
0.48
0.24
0.99
Gly
171
180
184
188
10.0
0.11
0.02
0.64
Pro
82.3
79.6
86.1
85.0
4.56
0.20
0.16
0.72
Tyr
105
99.9
102
105
5.0
0.81
0.94
0.37
Total NEAA
579
566
591
601
20.9
0.26
0.12
0.38
1
NALM = control (0 g/d) vs. NALM treatments; L = linear effect of increasing NALM; Q = quadratic effect of increasing NALM.
table continues
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2

NEFA = nonesterified fatty acids.
EAA = essential AA.
4
NEAA = non-essential AA
3
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CONCLUSIONS

The developmental NALM product was supplemented in a typical lactation diet in the
current study with the expectation of improving the conversion of feed inputs into
production outputs through more efficient partitioning of nutrients and energy in mid to
late lactating Holstein dairy cows. A linear increase in DMI was observed with increasing
supplementation of NALM, which may potentially be related to a linear increase in MCP
yield. However, we have yet to investigate the potential stimulatory effects of NALM
supplementation on the rumen microbiota and also the presence and concentration of the
aminoacylase enzyme in the rumen, which may contribute to identifying additional
evidence for the positive effect of supplementing NALM in lactation diets. The increase
in DMI allowed for more nutrients and energy to be partitioned to different physiological
processes, but because of the stage of lactation of cows tested in the present study, the
extra energy ingested was partitioned to both milk production and BW gain which
resulted in a quadratic increase in milk yield with an increase in milk protein yield.
Caution should be exerted to extrapolate overall data of BW and net energy utilization in
the current study due to the small number of animals (n = 8) and the short length of data
collection and, therefore, further investigation is needed to confirm our data with a
relatively longer period of experimentation and with a larger number of experimental
animals. From an environmental standpoint, the decrease in urinary N excretion due to
NALM supplementation highlights an additional benefit because of the decrease in the
most volatile form of ammonia excreted by cows, but with the linear increase in DMI,
fecal N excretion also linearly increased, possibly counteracting the beneficial effect of
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decreasing urinary N excretion. The increase in DMI without a subsequent increase in
milk yield decreased the N utilization efficiency in the current study, which opposes the
general goal of the dairy industry today. Overall, the current study suggests that NALM
supplementation has a positive impact on increasing milk protein yield and energy
partitioning of dairy cows in mid to late lactation by aiding in BW gain, potentially
affecting the fertility and longevity of high-producing dairy cows.
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Appendix. The relationship between N intake and excretion of N into milk, feces, or
urine by mid to late lactating Holstein dairy cows supplemented with N-acetyl-L-Met
(NALM) with varying doses (n = 32 on individual data set).
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